JP2018052904A - External composition - Google Patents
External composition Download PDFInfo
- Publication number
- JP2018052904A JP2018052904A JP2016194611A JP2016194611A JP2018052904A JP 2018052904 A JP2018052904 A JP 2018052904A JP 2016194611 A JP2016194611 A JP 2016194611A JP 2016194611 A JP2016194611 A JP 2016194611A JP 2018052904 A JP2018052904 A JP 2018052904A
- Authority
- JP
- Japan
- Prior art keywords
- fatty acid
- extract
- composition
- acid
- skin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 73
- 235000014113 dietary fatty acids Nutrition 0.000 claims abstract description 73
- 239000000194 fatty acid Substances 0.000 claims abstract description 73
- 229930195729 fatty acid Natural products 0.000 claims abstract description 73
- -1 fatty acid salt Chemical class 0.000 claims abstract description 52
- 150000004665 fatty acids Chemical class 0.000 claims abstract description 48
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 claims abstract description 28
- 238000004519 manufacturing process Methods 0.000 claims description 26
- 238000000034 method Methods 0.000 claims description 19
- 239000003513 alkali Substances 0.000 claims description 13
- 125000004432 carbon atom Chemical group C* 0.000 claims description 13
- 239000002994 raw material Substances 0.000 claims description 12
- 229920006395 saturated elastomer Polymers 0.000 claims description 10
- 150000004671 saturated fatty acids Chemical class 0.000 claims description 7
- 238000002156 mixing Methods 0.000 claims description 6
- 238000007127 saponification reaction Methods 0.000 claims description 6
- 235000021122 unsaturated fatty acids Nutrition 0.000 claims description 5
- 150000004670 unsaturated fatty acids Chemical class 0.000 claims description 5
- 230000008569 process Effects 0.000 claims description 3
- 235000003441 saturated fatty acids Nutrition 0.000 claims description 3
- 230000008591 skin barrier function Effects 0.000 abstract description 21
- 208000024891 symptom Diseases 0.000 abstract description 12
- 230000006866 deterioration Effects 0.000 abstract description 6
- 206010061218 Inflammation Diseases 0.000 abstract description 4
- 230000004054 inflammatory process Effects 0.000 abstract description 4
- 208000003251 Pruritus Diseases 0.000 abstract description 3
- 230000004215 skin function Effects 0.000 abstract description 2
- 239000000284 extract Substances 0.000 description 55
- 210000003491 skin Anatomy 0.000 description 38
- 239000002537 cosmetic Substances 0.000 description 21
- 239000007788 liquid Substances 0.000 description 21
- 239000006071 cream Substances 0.000 description 19
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 18
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 16
- 238000012360 testing method Methods 0.000 description 16
- 240000007594 Oryza sativa Species 0.000 description 15
- 235000007164 Oryza sativa Nutrition 0.000 description 15
- 235000009566 rice Nutrition 0.000 description 15
- 150000002334 glycols Chemical class 0.000 description 14
- 239000000839 emulsion Substances 0.000 description 13
- 239000003814 drug Substances 0.000 description 12
- 230000002708 enhancing effect Effects 0.000 description 12
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 9
- KEMQGTRYUADPNZ-UHFFFAOYSA-N heptadecanoic acid Chemical compound CCCCCCCCCCCCCCCCC(O)=O KEMQGTRYUADPNZ-UHFFFAOYSA-N 0.000 description 8
- IPCSVZSSVZVIGE-UHFFFAOYSA-N hexadecanoic acid Chemical compound CCCCCCCCCCCCCCCC(O)=O IPCSVZSSVZVIGE-UHFFFAOYSA-N 0.000 description 8
- 239000004310 lactic acid Substances 0.000 description 8
- 235000014655 lactic acid Nutrition 0.000 description 8
- WQEPLUUGTLDZJY-UHFFFAOYSA-N pentadecanoic acid Chemical compound CCCCCCCCCCCCCCC(O)=O WQEPLUUGTLDZJY-UHFFFAOYSA-N 0.000 description 8
- 239000000843 powder Substances 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 230000037303 wrinkles Effects 0.000 description 8
- 241000894006 Bacteria Species 0.000 description 7
- 150000001412 amines Chemical class 0.000 description 7
- 229940079593 drug Drugs 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 6
- XSQUKJJJFZCRTK-UHFFFAOYSA-N Urea Chemical compound NC(N)=O XSQUKJJJFZCRTK-UHFFFAOYSA-N 0.000 description 6
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 5
- 239000002202 Polyethylene glycol Substances 0.000 description 5
- 235000002597 Solanum melongena Nutrition 0.000 description 5
- 244000061458 Solanum melongena Species 0.000 description 5
- 230000032683 aging Effects 0.000 description 5
- 150000001298 alcohols Chemical class 0.000 description 5
- 239000013566 allergen Substances 0.000 description 5
- 230000004888 barrier function Effects 0.000 description 5
- 230000000052 comparative effect Effects 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- 229920001223 polyethylene glycol Polymers 0.000 description 5
- 239000000047 product Substances 0.000 description 5
- 230000005068 transpiration Effects 0.000 description 5
- WNWHHMBRJJOGFJ-UHFFFAOYSA-N 16-methylheptadecan-1-ol Chemical compound CC(C)CCCCCCCCCCCCCCCO WNWHHMBRJJOGFJ-UHFFFAOYSA-N 0.000 description 4
- 240000000731 Fagus sylvatica Species 0.000 description 4
- 235000010099 Fagus sylvatica Nutrition 0.000 description 4
- YNAVUWVOSKDBBP-UHFFFAOYSA-N Morpholine Chemical compound C1COCCN1 YNAVUWVOSKDBBP-UHFFFAOYSA-N 0.000 description 4
- 235000021314 Palmitic acid Nutrition 0.000 description 4
- 235000021355 Stearic acid Nutrition 0.000 description 4
- 239000002253 acid Substances 0.000 description 4
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 4
- GOQYKNQRPGWPLP-UHFFFAOYSA-N heptadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 4
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 4
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 4
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 4
- 239000002674 ointment Substances 0.000 description 4
- SECPZKHBENQXJG-FPLPWBNLSA-N palmitoleic acid Chemical compound CCCCCC\C=C/CCCCCCCC(O)=O SECPZKHBENQXJG-FPLPWBNLSA-N 0.000 description 4
- 238000002360 preparation method Methods 0.000 description 4
- 238000007665 sagging Methods 0.000 description 4
- 230000009759 skin aging Effects 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000008117 stearic acid Substances 0.000 description 4
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 3
- 229940058015 1,3-butylene glycol Drugs 0.000 description 3
- OYAQUBKYAKSHOA-UHFFFAOYSA-N 2-(2-hydroxy-5-propylphenyl)-4-propylphenol Chemical compound CCCC1=CC=C(O)C(C=2C(=CC=C(CCC)C=2)O)=C1 OYAQUBKYAKSHOA-UHFFFAOYSA-N 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical class N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 3
- 102000008186 Collagen Human genes 0.000 description 3
- 108010035532 Collagen Proteins 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- 240000002853 Nelumbo nucifera Species 0.000 description 3
- 235000006508 Nelumbo nucifera Nutrition 0.000 description 3
- 235000006510 Nelumbo pentapetala Nutrition 0.000 description 3
- 229910019142 PO4 Inorganic materials 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 244000062793 Sorghum vulgare Species 0.000 description 3
- 235000021307 Triticum Nutrition 0.000 description 3
- 244000098338 Triticum aestivum Species 0.000 description 3
- 229930003427 Vitamin E Natural products 0.000 description 3
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 3
- 239000000443 aerosol Substances 0.000 description 3
- 229910052783 alkali metal Inorganic materials 0.000 description 3
- 229940069521 aloe extract Drugs 0.000 description 3
- 235000019437 butane-1,3-diol Nutrition 0.000 description 3
- 239000004202 carbamide Substances 0.000 description 3
- 235000013339 cereals Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 229920001436 collagen Polymers 0.000 description 3
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical compound CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 3
- 238000004945 emulsification Methods 0.000 description 3
- 230000006870 function Effects 0.000 description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 3
- 235000011187 glycerol Nutrition 0.000 description 3
- 229920002674 hyaluronan Polymers 0.000 description 3
- 229960003160 hyaluronic acid Drugs 0.000 description 3
- 235000019713 millet Nutrition 0.000 description 3
- 235000021317 phosphate Nutrition 0.000 description 3
- 239000011505 plaster Substances 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000019165 vitamin E Nutrition 0.000 description 3
- 229940046009 vitamin E Drugs 0.000 description 3
- 239000011709 vitamin E Substances 0.000 description 3
- WCDDVEOXEIYWFB-VXORFPGASA-N (2s,3s,4r,5r,6r)-3-[(2s,3r,5s,6r)-3-acetamido-5-hydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-4,5,6-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@@H]1C[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](C(O)=O)O[C@@H](O)[C@H](O)[C@H]1O WCDDVEOXEIYWFB-VXORFPGASA-N 0.000 description 2
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 2
- CUXYLFPMQMFGPL-UHFFFAOYSA-N (9Z,11E,13E)-9,11,13-Octadecatrienoic acid Natural products CCCCC=CC=CC=CCCCCCCCC(O)=O CUXYLFPMQMFGPL-UHFFFAOYSA-N 0.000 description 2
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 2
- HXKKHQJGJAFBHI-UHFFFAOYSA-N 1-aminopropan-2-ol Chemical compound CC(O)CN HXKKHQJGJAFBHI-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- IOAOAKDONABGPZ-UHFFFAOYSA-N 2-amino-2-ethylpropane-1,3-diol Chemical compound CCC(N)(CO)CO IOAOAKDONABGPZ-UHFFFAOYSA-N 0.000 description 2
- UXFQFBNBSPQBJW-UHFFFAOYSA-N 2-amino-2-methylpropane-1,3-diol Chemical compound OCC(N)(C)CO UXFQFBNBSPQBJW-UHFFFAOYSA-N 0.000 description 2
- JCBPETKZIGVZRE-UHFFFAOYSA-N 2-aminobutan-1-ol Chemical compound CCC(N)CO JCBPETKZIGVZRE-UHFFFAOYSA-N 0.000 description 2
- TWJNQYPJQDRXPH-UHFFFAOYSA-N 2-cyanobenzohydrazide Chemical compound NNC(=O)C1=CC=CC=C1C#N TWJNQYPJQDRXPH-UHFFFAOYSA-N 0.000 description 2
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 2
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 2
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 2
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 2
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical class OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 2
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 2
- 241001474374 Blennius Species 0.000 description 2
- 241001107116 Castanospermum australe Species 0.000 description 2
- UDMBCSSLTHHNCD-UHFFFAOYSA-N Coenzym Q(11) Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(COP(O)(O)=O)C(O)C1O UDMBCSSLTHHNCD-UHFFFAOYSA-N 0.000 description 2
- 241000254173 Coleoptera Species 0.000 description 2
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 2
- ILKBHIBYKSHTKQ-UHFFFAOYSA-N Diisopropylamine dichloroacetate Chemical compound OC(=O)C(Cl)Cl.CC(C)NC(C)C ILKBHIBYKSHTKQ-UHFFFAOYSA-N 0.000 description 2
- 102000016942 Elastin Human genes 0.000 description 2
- 108010014258 Elastin Proteins 0.000 description 2
- 235000010469 Glycine max Nutrition 0.000 description 2
- 244000068988 Glycine max Species 0.000 description 2
- 229920002683 Glycosaminoglycan Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 2
- QIGBRXMKCJKVMJ-UHFFFAOYSA-N Hydroquinone Chemical compound OC1=CC=C(O)C=C1 QIGBRXMKCJKVMJ-UHFFFAOYSA-N 0.000 description 2
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 2
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 2
- 235000021360 Myristic acid Nutrition 0.000 description 2
- TUNFSRHWOTWDNC-UHFFFAOYSA-N Myristic acid Natural products CCCCCCCCCCCCCC(O)=O TUNFSRHWOTWDNC-UHFFFAOYSA-N 0.000 description 2
- OPKOKAMJFNKNAS-UHFFFAOYSA-N N-methylethanolamine Chemical compound CNCCO OPKOKAMJFNKNAS-UHFFFAOYSA-N 0.000 description 2
- MBBZMMPHUWSWHV-BDVNFPICSA-N N-methylglucamine Chemical compound CNC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO MBBZMMPHUWSWHV-BDVNFPICSA-N 0.000 description 2
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 2
- 239000005642 Oleic acid Substances 0.000 description 2
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 2
- 235000006484 Paeonia officinalis Nutrition 0.000 description 2
- 244000170916 Paeonia officinalis Species 0.000 description 2
- 235000021319 Palmitoleic acid Nutrition 0.000 description 2
- 240000004371 Panax ginseng Species 0.000 description 2
- 244000046052 Phaseolus vulgaris Species 0.000 description 2
- 235000010627 Phaseolus vulgaris Nutrition 0.000 description 2
- 239000004698 Polyethylene Substances 0.000 description 2
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 2
- ZTHYODDOHIVTJV-UHFFFAOYSA-N Propyl gallate Chemical compound CCCOC(=O)C1=CC(O)=C(O)C(O)=C1 ZTHYODDOHIVTJV-UHFFFAOYSA-N 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- GSEJCLTVZPLZKY-UHFFFAOYSA-N Triethanolamine Chemical compound OCCN(CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-N 0.000 description 2
- SLINHMUFWFWBMU-UHFFFAOYSA-N Triisopropanolamine Chemical compound CC(O)CN(CC(C)O)CC(C)O SLINHMUFWFWBMU-UHFFFAOYSA-N 0.000 description 2
- 235000021322 Vaccenic acid Nutrition 0.000 description 2
- UWHZIFQPPBDJPM-FPLPWBNLSA-M Vaccenic acid Natural products CCCCCC\C=C/CCCCCCCCCC([O-])=O UWHZIFQPPBDJPM-FPLPWBNLSA-M 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- XLOMVQKBTHCTTD-UHFFFAOYSA-N Zinc monoxide Chemical compound [Zn]=O XLOMVQKBTHCTTD-UHFFFAOYSA-N 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000012190 activator Substances 0.000 description 2
- LNQVTSROQXJCDD-UHFFFAOYSA-N adenosine monophosphate Natural products C1=NC=2C(N)=NC=NC=2N1C1OC(CO)C(OP(O)(O)=O)C1O LNQVTSROQXJCDD-UHFFFAOYSA-N 0.000 description 2
- 229910000288 alkali metal carbonate Inorganic materials 0.000 description 2
- 150000008041 alkali metal carbonates Chemical class 0.000 description 2
- 229910000272 alkali metal oxide Inorganic materials 0.000 description 2
- 150000001340 alkali metals Chemical class 0.000 description 2
- 229910052784 alkaline earth metal Inorganic materials 0.000 description 2
- 229910001860 alkaline earth metal hydroxide Chemical class 0.000 description 2
- 150000003973 alkyl amines Chemical class 0.000 description 2
- 125000005037 alkyl phenyl group Chemical group 0.000 description 2
- CUXYLFPMQMFGPL-SUTYWZMXSA-N all-trans-octadeca-9,11,13-trienoic acid Chemical compound CCCC\C=C\C=C\C=C\CCCCCCCC(O)=O CUXYLFPMQMFGPL-SUTYWZMXSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 229960000458 allantoin Drugs 0.000 description 2
- 229940061720 alpha hydroxy acid Drugs 0.000 description 2
- 150000001280 alpha hydroxy acids Chemical class 0.000 description 2
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 229960002298 aminohydroxybutyric acid Drugs 0.000 description 2
- CBTVGIZVANVGBH-UHFFFAOYSA-N aminomethyl propanol Chemical compound CC(C)(N)CO CBTVGIZVANVGBH-UHFFFAOYSA-N 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 239000007864 aqueous solution Substances 0.000 description 2
- 239000003899 bactericide agent Substances 0.000 description 2
- TZCXTZWJZNENPQ-UHFFFAOYSA-L barium sulfate Chemical compound [Ba+2].[O-]S([O-])(=O)=O TZCXTZWJZNENPQ-UHFFFAOYSA-L 0.000 description 2
- 235000021279 black bean Nutrition 0.000 description 2
- 229940041514 candida albicans extract Drugs 0.000 description 2
- 229960000541 cetyl alcohol Drugs 0.000 description 2
- SECPZKHBENQXJG-UHFFFAOYSA-N cis-palmitoleic acid Natural products CCCCCCC=CCCCCCCCC(O)=O SECPZKHBENQXJG-UHFFFAOYSA-N 0.000 description 2
- 229940105039 coconut extract Drugs 0.000 description 2
- ACTIUHUUMQJHFO-UPTCCGCDSA-N coenzyme Q10 Chemical compound COC1=C(OC)C(=O)C(C\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CC\C=C(/C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UPTCCGCDSA-N 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- ZBCBWPMODOFKDW-UHFFFAOYSA-N diethanolamine Chemical compound OCCNCCO ZBCBWPMODOFKDW-UHFFFAOYSA-N 0.000 description 2
- 229940043237 diethanolamine Drugs 0.000 description 2
- LVTYICIALWPMFW-UHFFFAOYSA-N diisopropanolamine Chemical compound CC(O)CNCC(C)O LVTYICIALWPMFW-UHFFFAOYSA-N 0.000 description 2
- 229940043276 diisopropanolamine Drugs 0.000 description 2
- 229940084113 diisopropylamine dichloroacetate Drugs 0.000 description 2
- 229920002549 elastin Polymers 0.000 description 2
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- YQGDEPYYFWUPGO-UHFFFAOYSA-N gamma-amino-beta-hydroxybutyric acid Chemical compound [NH3+]CC(O)CC([O-])=O YQGDEPYYFWUPGO-UHFFFAOYSA-N 0.000 description 2
- 235000008434 ginseng Nutrition 0.000 description 2
- 150000002357 guanidines Chemical class 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- 229940014041 hyaluronate Drugs 0.000 description 2
- 150000002443 hydroxylamines Chemical class 0.000 description 2
- 150000002466 imines Chemical class 0.000 description 2
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 2
- 229940102253 isopropanolamine Drugs 0.000 description 2
- JJWLVOIRVHMVIS-UHFFFAOYSA-N isopropylamine Chemical compound CC(C)N JJWLVOIRVHMVIS-UHFFFAOYSA-N 0.000 description 2
- 230000007803 itching Effects 0.000 description 2
- GKQPCPXONLDCMU-CCEZHUSRSA-N lacidipine Chemical compound CCOC(=O)C1=C(C)NC(C)=C(C(=O)OCC)C1C1=CC=CC=C1\C=C\C(=O)OC(C)(C)C GKQPCPXONLDCMU-CCEZHUSRSA-N 0.000 description 2
- 235000020778 linoleic acid Nutrition 0.000 description 2
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- KQQKGWQCNNTQJW-UHFFFAOYSA-N linolenic acid Natural products CC=CCCC=CCC=CCCCCCCCC(O)=O KQQKGWQCNNTQJW-UHFFFAOYSA-N 0.000 description 2
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 2
- 229940055577 oleyl alcohol Drugs 0.000 description 2
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 2
- LBIYNOAMNIKVKF-FPLPWBNLSA-N palmitoleyl alcohol Chemical compound CCCCCC\C=C/CCCCCCCCO LBIYNOAMNIKVKF-FPLPWBNLSA-N 0.000 description 2
- LBIYNOAMNIKVKF-UHFFFAOYSA-N palmitoleyl alcohol Natural products CCCCCCC=CCCCCCCCCO LBIYNOAMNIKVKF-UHFFFAOYSA-N 0.000 description 2
- FJKROLUGYXJWQN-UHFFFAOYSA-N papa-hydroxy-benzoic acid Natural products OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 description 2
- REIUXOLGHVXAEO-UHFFFAOYSA-N pentadecan-1-ol Chemical compound CCCCCCCCCCCCCCCO REIUXOLGHVXAEO-UHFFFAOYSA-N 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000010452 phosphate Substances 0.000 description 2
- 210000002826 placenta Anatomy 0.000 description 2
- 229920000768 polyamine Polymers 0.000 description 2
- 229920000573 polyethylene Polymers 0.000 description 2
- 229910052700 potassium Inorganic materials 0.000 description 2
- 239000011591 potassium Substances 0.000 description 2
- BWHMMNNQKKPAPP-UHFFFAOYSA-L potassium carbonate Chemical compound [K+].[K+].[O-]C([O-])=O BWHMMNNQKKPAPP-UHFFFAOYSA-L 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 2
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical class O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 2
- 229940109850 royal jelly Drugs 0.000 description 2
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 2
- 235000005493 rutin Nutrition 0.000 description 2
- 229960004555 rutoside Drugs 0.000 description 2
- YGSDEFSMJLZEOE-UHFFFAOYSA-N salicylic acid Chemical compound OC(=O)C1=CC=CC=C1O YGSDEFSMJLZEOE-UHFFFAOYSA-N 0.000 description 2
- 239000011734 sodium Substances 0.000 description 2
- 229910052708 sodium Inorganic materials 0.000 description 2
- 239000000600 sorbitol Substances 0.000 description 2
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- HLZKNKRTKFSKGZ-UHFFFAOYSA-N tetradecan-1-ol Chemical compound CCCCCCCCCCCCCCO HLZKNKRTKFSKGZ-UHFFFAOYSA-N 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- UWHZIFQPPBDJPM-BQYQJAHWSA-N trans-vaccenic acid Chemical compound CCCCCC\C=C\CCCCCCCCCC(O)=O UWHZIFQPPBDJPM-BQYQJAHWSA-N 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 2
- 229960004418 trolamine Drugs 0.000 description 2
- 229960000281 trometamol Drugs 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000012138 yeast extract Substances 0.000 description 2
- HDTRYLNUVZCQOY-UHFFFAOYSA-N α-D-glucopyranosyl-α-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OC1C(O)C(O)C(O)C(CO)O1 HDTRYLNUVZCQOY-UHFFFAOYSA-N 0.000 description 1
- JXNPEDYJTDQORS-HZJYTTRNSA-N (9Z,12Z)-octadecadien-1-ol Chemical compound CCCCC\C=C/C\C=C/CCCCCCCCO JXNPEDYJTDQORS-HZJYTTRNSA-N 0.000 description 1
- AGBQKNBQESQNJD-SSDOTTSWSA-N (R)-lipoic acid Chemical compound OC(=O)CCCC[C@@H]1CCSS1 AGBQKNBQESQNJD-SSDOTTSWSA-N 0.000 description 1
- QGLWBTPVKHMVHM-KTKRTIGZSA-N (z)-octadec-9-en-1-amine Chemical class CCCCCCCC\C=C/CCCCCCCCN QGLWBTPVKHMVHM-KTKRTIGZSA-N 0.000 description 1
- 150000005207 1,3-dihydroxybenzenes Chemical class 0.000 description 1
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- FRPZMMHWLSIFAZ-UHFFFAOYSA-N 10-undecenoic acid Chemical compound OC(=O)CCCCCCCCC=C FRPZMMHWLSIFAZ-UHFFFAOYSA-N 0.000 description 1
- ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 2,3-dimethylbutane Chemical group CC(C)C(C)C ZFFMLCVRJBZUDZ-UHFFFAOYSA-N 0.000 description 1
- SMZOUWXMTYCWNB-UHFFFAOYSA-N 2-(2-methoxy-5-methylphenyl)ethanamine Chemical compound COC1=CC=C(C)C=C1CCN SMZOUWXMTYCWNB-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N 2-Propenoic acid Natural products OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- 229940100555 2-methyl-4-isothiazolin-3-one Drugs 0.000 description 1
- QCDWFXQBSFUVSP-UHFFFAOYSA-N 2-phenoxyethanol Chemical compound OCCOC1=CC=CC=C1 QCDWFXQBSFUVSP-UHFFFAOYSA-N 0.000 description 1
- GXNGGBMNYUHZOZ-UHFFFAOYSA-N 4-(1-hydroxybutyl)phenol Chemical compound CCCC(O)C1=CC=C(O)C=C1 GXNGGBMNYUHZOZ-UHFFFAOYSA-N 0.000 description 1
- KTXUGZHJVRHQGP-UHFFFAOYSA-N 4-Hydroxy-1-(3-pyridinyl)-1-butanone Chemical compound OCCCC(=O)C1=CC=CN=C1 KTXUGZHJVRHQGP-UHFFFAOYSA-N 0.000 description 1
- 240000002767 Acer grandidentatum Species 0.000 description 1
- 235000010319 Acer grandidentatum Nutrition 0.000 description 1
- 235000010328 Acer nigrum Nutrition 0.000 description 1
- 235000002629 Acer saccharinum Nutrition 0.000 description 1
- 235000010157 Acer saccharum subsp saccharum Nutrition 0.000 description 1
- 229920002126 Acrylic acid copolymer Polymers 0.000 description 1
- 241000251468 Actinopterygii Species 0.000 description 1
- 229920001817 Agar Polymers 0.000 description 1
- 239000005995 Aluminium silicate Substances 0.000 description 1
- QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
- ATRRKUHOCOJYRX-UHFFFAOYSA-N Ammonium bicarbonate Chemical compound [NH4+].OC([O-])=O ATRRKUHOCOJYRX-UHFFFAOYSA-N 0.000 description 1
- 229910000013 Ammonium bicarbonate Inorganic materials 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- 239000004254 Ammonium phosphate Substances 0.000 description 1
- 244000021317 Annona cherimola Species 0.000 description 1
- CAKGLMPBYAPFCR-UWBMNBDUSA-N Bemisiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O[C@@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@@H](CO)O1 CAKGLMPBYAPFCR-UWBMNBDUSA-N 0.000 description 1
- 235000018185 Betula X alpestris Nutrition 0.000 description 1
- 235000018212 Betula X uliginosa Nutrition 0.000 description 1
- 235000004936 Bromus mango Nutrition 0.000 description 1
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 description 1
- YDNKGFDKKRUKPY-JHOUSYSJSA-N C16 ceramide Natural products CCCCCCCCCCCCCCCC(=O)N[C@@H](CO)[C@H](O)C=CCCCCCCCCCCCCC YDNKGFDKKRUKPY-JHOUSYSJSA-N 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 244000025254 Cannabis sativa Species 0.000 description 1
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 1
- 235000014653 Carica parviflora Nutrition 0.000 description 1
- 241000195649 Chlorella <Chlorellales> Species 0.000 description 1
- GHXZTYHSJHQHIJ-UHFFFAOYSA-N Chlorhexidine Chemical compound C=1C=C(Cl)C=CC=1NC(N)=NC(N)=NCCCCCCN=C(N)N=C(N)NC1=CC=C(Cl)C=C1 GHXZTYHSJHQHIJ-UHFFFAOYSA-N 0.000 description 1
- 241000195628 Chlorophyta Species 0.000 description 1
- 229920002567 Chondroitin Polymers 0.000 description 1
- 241000243321 Cnidaria Species 0.000 description 1
- 235000013162 Cocos nucifera Nutrition 0.000 description 1
- 244000060011 Cocos nucifera Species 0.000 description 1
- ACTIUHUUMQJHFO-UHFFFAOYSA-N Coenzym Q10 Natural products COC1=C(OC)C(=O)C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)=C(C)C1=O ACTIUHUUMQJHFO-UHFFFAOYSA-N 0.000 description 1
- 241001635206 Conger conger Species 0.000 description 1
- 241000544061 Cuculus canorus Species 0.000 description 1
- 240000008067 Cucumis sativus Species 0.000 description 1
- 235000010799 Cucumis sativus var sativus Nutrition 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- 102000053602 DNA Human genes 0.000 description 1
- 108020004414 DNA Proteins 0.000 description 1
- MDNWOSOZYLHTCG-UHFFFAOYSA-N Dichlorophen Chemical compound OC1=CC=C(Cl)C=C1CC1=CC(Cl)=CC=C1O MDNWOSOZYLHTCG-UHFFFAOYSA-N 0.000 description 1
- AFSDNFLWKVMVRB-UHFFFAOYSA-N Ellagic acid Chemical compound OC1=C(O)C(OC2=O)=C3C4=C2C=C(O)C(O)=C4OC(=O)C3=C1 AFSDNFLWKVMVRB-UHFFFAOYSA-N 0.000 description 1
- ATJXMQHAMYVHRX-CPCISQLKSA-N Ellagic acid Natural products OC1=C(O)[C@H]2OC(=O)c3cc(O)c(O)c4OC(=O)C(=C1)[C@H]2c34 ATJXMQHAMYVHRX-CPCISQLKSA-N 0.000 description 1
- 229920002079 Ellagic acid Polymers 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 241000195955 Equisetum hyemale Species 0.000 description 1
- 229920000855 Fucoidan Polymers 0.000 description 1
- 235000017048 Garcinia mangostana Nutrition 0.000 description 1
- 240000006053 Garcinia mangostana Species 0.000 description 1
- 241001071795 Gentiana Species 0.000 description 1
- 239000009429 Ginkgo biloba extract Substances 0.000 description 1
- 241000282816 Giraffa camelopardalis Species 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- HTTJABKRGRZYRN-UHFFFAOYSA-N Heparin Chemical compound OC1C(NC(=O)C)C(O)OC(COS(O)(=O)=O)C1OC1C(OS(O)(=O)=O)C(O)C(OC2C(C(OS(O)(=O)=O)C(OC3C(C(O)C(O)C(O3)C(O)=O)OS(O)(=O)=O)C(CO)O2)NS(O)(=O)=O)C(C(O)=O)O1 HTTJABKRGRZYRN-UHFFFAOYSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 235000010254 Jasminum officinale Nutrition 0.000 description 1
- 240000005385 Jasminum sambac Species 0.000 description 1
- SSISHJJTAXXQAX-ZETCQYMHSA-N L-ergothioneine Chemical compound C[N+](C)(C)[C@H](C([O-])=O)CC1=CNC(=S)N1 SSISHJJTAXXQAX-ZETCQYMHSA-N 0.000 description 1
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 235000003956 Luffa Nutrition 0.000 description 1
- 244000050983 Luffa operculata Species 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- 229930182636 Magnolignan Natural products 0.000 description 1
- 241000218922 Magnoliophyta Species 0.000 description 1
- 240000007228 Mangifera indica Species 0.000 description 1
- 235000014826 Mangifera indica Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- CRJGESKKUOMBCT-VQTJNVASSA-N N-acetylsphinganine Chemical compound CCCCCCCCCCCCCCC[C@@H](O)[C@H](CO)NC(C)=O CRJGESKKUOMBCT-VQTJNVASSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- REYJJPSVUYRZGE-UHFFFAOYSA-N Octadecylamine Chemical class CCCCCCCCCCCCCCCCCCN REYJJPSVUYRZGE-UHFFFAOYSA-N 0.000 description 1
- 235000002789 Panax ginseng Nutrition 0.000 description 1
- 235000005035 Panax pseudoginseng ssp. pseudoginseng Nutrition 0.000 description 1
- 235000003140 Panax quinquefolius Nutrition 0.000 description 1
- 235000012110 Pandanus odorus Nutrition 0.000 description 1
- 244000180021 Pandanus odorus Species 0.000 description 1
- 239000004264 Petrolatum Substances 0.000 description 1
- 241000199919 Phaeophyceae Species 0.000 description 1
- 108010020346 Polyglutamic Acid Proteins 0.000 description 1
- 229920001214 Polysorbate 60 Polymers 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- 241000241413 Propolis Species 0.000 description 1
- 241000206572 Rhodophyta Species 0.000 description 1
- 235000002953 Saxifraga stolonifera Nutrition 0.000 description 1
- 244000288377 Saxifraga stolonifera Species 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 235000009184 Spondias indica Nutrition 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 238000000692 Student's t-test Methods 0.000 description 1
- QAOWNCQODCNURD-UHFFFAOYSA-L Sulfate Chemical compound [O-]S([O-])(=O)=O QAOWNCQODCNURD-UHFFFAOYSA-L 0.000 description 1
- 241001530102 Tabebuia Species 0.000 description 1
- 235000006468 Thea sinensis Nutrition 0.000 description 1
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 1
- 229920001615 Tragacanth Polymers 0.000 description 1
- HDTRYLNUVZCQOY-WSWWMNSNSA-N Trehalose Natural products O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-WSWWMNSNSA-N 0.000 description 1
- 235000017537 Vaccinium myrtillus Nutrition 0.000 description 1
- 244000078534 Vaccinium myrtillus Species 0.000 description 1
- 235000011453 Vigna umbellata Nutrition 0.000 description 1
- 240000001417 Vigna umbellata Species 0.000 description 1
- 239000005862 Whey Substances 0.000 description 1
- 102000007544 Whey Proteins Human genes 0.000 description 1
- 108010046377 Whey Proteins Proteins 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 240000008042 Zea mays Species 0.000 description 1
- 235000005824 Zea mays ssp. parviglumis Nutrition 0.000 description 1
- 235000002017 Zea mays subsp mays Nutrition 0.000 description 1
- 241001247821 Ziziphus Species 0.000 description 1
- 235000001329 Ziziphus joazeiro Nutrition 0.000 description 1
- 244000158786 Ziziphus joazeiro Species 0.000 description 1
- JBBRZDLNVILTDL-XNTGVSEISA-N [(3s,8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylheptan-2-yl]-2,3,4,7,8,9,11,12,14,15,16,17-dodecahydro-1h-cyclopenta[a]phenanthren-3-yl] 16-methylheptadecanoate Chemical compound C([C@@H]12)C[C@]3(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@H]3[C@@H]1CC=C1[C@]2(C)CC[C@H](OC(=O)CCCCCCCCCCCCCCC(C)C)C1 JBBRZDLNVILTDL-XNTGVSEISA-N 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 239000008272 agar Substances 0.000 description 1
- 229940023476 agar Drugs 0.000 description 1
- 235000010419 agar Nutrition 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- 150000004781 alginic acids Chemical class 0.000 description 1
- 229910000318 alkali metal phosphate Inorganic materials 0.000 description 1
- 150000005215 alkyl ethers Chemical class 0.000 description 1
- 150000008051 alkyl sulfates Chemical class 0.000 description 1
- 229940006091 aloe polysaccharide Drugs 0.000 description 1
- HDTRYLNUVZCQOY-LIZSDCNHSA-N alpha,alpha-trehalose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 HDTRYLNUVZCQOY-LIZSDCNHSA-N 0.000 description 1
- AGBQKNBQESQNJD-UHFFFAOYSA-N alpha-Lipoic acid Natural products OC(=O)CCCCC1CCSS1 AGBQKNBQESQNJD-UHFFFAOYSA-N 0.000 description 1
- 235000012211 aluminium silicate Nutrition 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 235000012538 ammonium bicarbonate Nutrition 0.000 description 1
- 239000001099 ammonium carbonate Substances 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 229910000148 ammonium phosphate Inorganic materials 0.000 description 1
- 235000019289 ammonium phosphates Nutrition 0.000 description 1
- 239000002280 amphoteric surfactant Substances 0.000 description 1
- 239000003945 anionic surfactant Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 239000004599 antimicrobial Substances 0.000 description 1
- 235000019206 astragalus extract Nutrition 0.000 description 1
- 239000000305 astragalus gummifer gum Substances 0.000 description 1
- 229910052788 barium Inorganic materials 0.000 description 1
- DSAJWYNOEDNPEQ-UHFFFAOYSA-N barium atom Chemical compound [Ba] DSAJWYNOEDNPEQ-UHFFFAOYSA-N 0.000 description 1
- 230000037365 barrier function of the epidermis Effects 0.000 description 1
- 238000003287 bathing Methods 0.000 description 1
- 229940069765 bean extract Drugs 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- BUOSLGZEBFSUDD-BGPZCGNYSA-N bis[(1s,3s,4r,5r)-4-methoxycarbonyl-8-methyl-8-azabicyclo[3.2.1]octan-3-yl] 2,4-diphenylcyclobutane-1,3-dicarboxylate Chemical class O([C@H]1C[C@@H]2CC[C@@H](N2C)[C@H]1C(=O)OC)C(=O)C1C(C=2C=CC=CC=2)C(C(=O)O[C@@H]2[C@@H]([C@H]3CC[C@H](N3C)C2)C(=O)OC)C1C1=CC=CC=C1 BUOSLGZEBFSUDD-BGPZCGNYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- KHAVLLBUVKBTBG-UHFFFAOYSA-N caproleic acid Natural products OC(=O)CCCCCCCC=C KHAVLLBUVKBTBG-UHFFFAOYSA-N 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 239000001768 carboxy methyl cellulose Substances 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 229920003090 carboxymethyl hydroxyethyl cellulose Polymers 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- 229940008396 carrot extract Drugs 0.000 description 1
- 239000004359 castor oil Substances 0.000 description 1
- 235000019438 castor oil Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 229940106189 ceramide Drugs 0.000 description 1
- ZVEQCJWYRWKARO-UHFFFAOYSA-N ceramide Natural products CCCCCCCCCCCCCCC(O)C(=O)NC(CO)C(O)C=CCCC=C(C)CCCCCCCCC ZVEQCJWYRWKARO-UHFFFAOYSA-N 0.000 description 1
- 229940119217 chamomile extract Drugs 0.000 description 1
- 235000020221 chamomile extract Nutrition 0.000 description 1
- 239000007795 chemical reaction product Substances 0.000 description 1
- 235000012547 cherimoya Nutrition 0.000 description 1
- 229960003260 chlorhexidine Drugs 0.000 description 1
- 229940073724 cholesteryl isostearate Drugs 0.000 description 1
- DLGJWSVWTWEWBJ-HGGSSLSASA-N chondroitin Chemical compound CC(O)=N[C@@H]1[C@H](O)O[C@H](CO)[C@H](O)[C@@H]1OC1[C@H](O)[C@H](O)C=C(C(O)=O)O1 DLGJWSVWTWEWBJ-HGGSSLSASA-N 0.000 description 1
- 235000017471 coenzyme Q10 Nutrition 0.000 description 1
- 239000000306 component Substances 0.000 description 1
- 238000013329 compounding Methods 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 235000005822 corn Nutrition 0.000 description 1
- 235000013365 dairy product Nutrition 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 210000004207 dermis Anatomy 0.000 description 1
- MNNHAPBLZZVQHP-UHFFFAOYSA-N diammonium hydrogen phosphate Chemical compound [NH4+].[NH4+].OP([O-])([O-])=O MNNHAPBLZZVQHP-UHFFFAOYSA-N 0.000 description 1
- 229960003887 dichlorophen Drugs 0.000 description 1
- 229940043279 diisopropylamine Drugs 0.000 description 1
- KCIDZIIHRGYJAE-YGFYJFDDSA-L dipotassium;[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] phosphate Chemical class [K+].[K+].OC[C@H]1O[C@H](OP([O-])([O-])=O)[C@H](O)[C@@H](O)[C@H]1O KCIDZIIHRGYJAE-YGFYJFDDSA-L 0.000 description 1
- 229940012466 egg shell membrane Drugs 0.000 description 1
- 229960002852 ellagic acid Drugs 0.000 description 1
- 235000004132 ellagic acid Nutrition 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 229940093497 ergothioneine Drugs 0.000 description 1
- 229960004756 ethanol Drugs 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 238000011156 evaluation Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 150000002191 fatty alcohols Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000000499 gel Substances 0.000 description 1
- 229940068052 ginkgo biloba extract Drugs 0.000 description 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 description 1
- 229930182478 glucoside Natural products 0.000 description 1
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 description 1
- 229960004949 glycyrrhizic acid Drugs 0.000 description 1
- 239000001685 glycyrrhizic acid Substances 0.000 description 1
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 description 1
- 235000019410 glycyrrhizin Nutrition 0.000 description 1
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920000669 heparin Polymers 0.000 description 1
- 229960002897 heparin Drugs 0.000 description 1
- ACGUYXCXAPNIKK-UHFFFAOYSA-N hexachlorophene Chemical compound OC1=C(Cl)C=C(Cl)C(Cl)=C1CC1=C(O)C(Cl)=CC(Cl)=C1Cl ACGUYXCXAPNIKK-UHFFFAOYSA-N 0.000 description 1
- 229960004068 hexachlorophene Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 229960000443 hydrochloric acid Drugs 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical class C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 1
- 230000005722 itchiness Effects 0.000 description 1
- NLYAJNPCOHFWQQ-UHFFFAOYSA-N kaolin Chemical compound O.O.O=[Al]O[Si](=O)O[Si](=O)O[Al]=O NLYAJNPCOHFWQQ-UHFFFAOYSA-N 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000021374 legumes Nutrition 0.000 description 1
- 229940069445 licorice extract Drugs 0.000 description 1
- 239000000865 liniment Substances 0.000 description 1
- 229940040145 liniment Drugs 0.000 description 1
- JXNPEDYJTDQORS-UHFFFAOYSA-N linoleyl alcohol Natural products CCCCCC=CCC=CCCCCCCCCO JXNPEDYJTDQORS-UHFFFAOYSA-N 0.000 description 1
- 239000007934 lip balm Substances 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 235000019136 lipoic acid Nutrition 0.000 description 1
- 229940057995 liquid paraffin Drugs 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- VTHJTEIRLNZDEV-UHFFFAOYSA-L magnesium dihydroxide Chemical compound [OH-].[OH-].[Mg+2] VTHJTEIRLNZDEV-UHFFFAOYSA-L 0.000 description 1
- 239000000347 magnesium hydroxide Substances 0.000 description 1
- 229910001862 magnesium hydroxide Inorganic materials 0.000 description 1
- 239000000395 magnesium oxide Substances 0.000 description 1
- CPLXHLVBOLITMK-UHFFFAOYSA-N magnesium oxide Inorganic materials [Mg]=O CPLXHLVBOLITMK-UHFFFAOYSA-N 0.000 description 1
- AXZKOIWUVFPNLO-UHFFFAOYSA-N magnesium;oxygen(2-) Chemical compound [O-2].[Mg+2] AXZKOIWUVFPNLO-UHFFFAOYSA-N 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 229940117841 methacrylic acid copolymer Drugs 0.000 description 1
- 229920003145 methacrylic acid copolymer Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- FAARLWTXUUQFSN-UHFFFAOYSA-N methylellagic acid Natural products O1C(=O)C2=CC(O)=C(O)C3=C2C2=C1C(OC)=C(O)C=C2C(=O)O3 FAARLWTXUUQFSN-UHFFFAOYSA-N 0.000 description 1
- BEGLCMHJXHIJLR-UHFFFAOYSA-N methylisothiazolinone Chemical compound CN1SC=CC1=O BEGLCMHJXHIJLR-UHFFFAOYSA-N 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- 229940043348 myristyl alcohol Drugs 0.000 description 1
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 1
- 235000013557 nattō Nutrition 0.000 description 1
- VVGIYYKRAMHVLU-UHFFFAOYSA-N newbouldiamide Natural products CCCCCCCCCCCCCCCCCCCC(O)C(O)C(O)C(CO)NC(=O)CCCCCCCCCCCCCCCCC VVGIYYKRAMHVLU-UHFFFAOYSA-N 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 239000002736 nonionic surfactant Substances 0.000 description 1
- 239000004745 nonwoven fabric Substances 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- ALSTYHKOOCGGFT-MDZDMXLPSA-N oleyl alcohol Chemical compound CCCCCCCC\C=C\CCCCCCCCO ALSTYHKOOCGGFT-MDZDMXLPSA-N 0.000 description 1
- 235000020333 oolong tea Nutrition 0.000 description 1
- RVTZCBVAJQQJTK-UHFFFAOYSA-N oxygen(2-);zirconium(4+) Chemical compound [O-2].[O-2].[Zr+4] RVTZCBVAJQQJTK-UHFFFAOYSA-N 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 235000019809 paraffin wax Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 229940066842 petrolatum Drugs 0.000 description 1
- 150000002989 phenols Chemical class 0.000 description 1
- 229960005323 phenoxyethanol Drugs 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 150000003013 phosphoric acid derivatives Chemical class 0.000 description 1
- 239000000049 pigment Substances 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920002643 polyglutamic acid Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 1
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 1
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 1
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 1
- 239000011736 potassium bicarbonate Substances 0.000 description 1
- 229910000028 potassium bicarbonate Inorganic materials 0.000 description 1
- 235000015497 potassium bicarbonate Nutrition 0.000 description 1
- 229910000027 potassium carbonate Inorganic materials 0.000 description 1
- 235000011181 potassium carbonates Nutrition 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- YRJKYHIIYRGTCC-UHFFFAOYSA-M potassium;2-hydroxy-4-methoxybenzoate Chemical compound [K+].COC1=CC=C(C([O-])=O)C(O)=C1 YRJKYHIIYRGTCC-UHFFFAOYSA-M 0.000 description 1
- 229940069949 propolis Drugs 0.000 description 1
- 239000000473 propyl gallate Substances 0.000 description 1
- 235000010388 propyl gallate Nutrition 0.000 description 1
- 229940075579 propyl gallate Drugs 0.000 description 1
- 125000001436 propyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 150000003242 quaternary ammonium salts Chemical class 0.000 description 1
- NPCOQXAVBJJZBQ-UHFFFAOYSA-N reduced coenzyme Q9 Natural products COC1=C(O)C(C)=C(CC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)CCC=C(C)C)C(O)=C1OC NPCOQXAVBJJZBQ-UHFFFAOYSA-N 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- 229940119485 safflower extract Drugs 0.000 description 1
- 229960004889 salicylic acid Drugs 0.000 description 1
- 235000014102 seafood Nutrition 0.000 description 1
- 230000036620 skin dryness Effects 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- 235000017550 sodium carbonate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229940045920 sodium pyrrolidone carboxylate Drugs 0.000 description 1
- HYRLWUFWDYFEES-UHFFFAOYSA-M sodium;2-oxopyrrolidine-1-carboxylate Chemical compound [Na+].[O-]C(=O)N1CCCC1=O HYRLWUFWDYFEES-UHFFFAOYSA-M 0.000 description 1
- 229940030961 sorghum extract Drugs 0.000 description 1
- 235000020712 soy bean extract Nutrition 0.000 description 1
- 239000008347 soybean phospholipid Substances 0.000 description 1
- 238000005507 spraying Methods 0.000 description 1
- 229940032094 squalane Drugs 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 235000012069 sugar maple Nutrition 0.000 description 1
- 229920001059 synthetic polymer Polymers 0.000 description 1
- 238000012353 t test Methods 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- 229960002663 thioctic acid Drugs 0.000 description 1
- 210000001519 tissue Anatomy 0.000 description 1
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 1
- 230000000699 topical effect Effects 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- 229940035936 ubiquinone Drugs 0.000 description 1
- 238000009281 ultraviolet germicidal irradiation Methods 0.000 description 1
- 229960002703 undecylenic acid Drugs 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
- 239000011787 zinc oxide Substances 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
- 229910001928 zirconium oxide Inorganic materials 0.000 description 1
Abstract
Description
本発明は、外用組成物に関する。 The present invention relates to a composition for external use.
表皮層は、厚みがわずか20μmの組織であり、紫外線やアレルゲンなどの外部刺激から生体を防御するバリア機能を担っている。この表皮層のバリア機能が破綻することにより、上記外部刺激が皮膚内に侵入し、肌荒れ、しみ、シワ、ハリの低下、及び肌のたるみ等の症状や、アレルゲンの進入による痒みや炎症などの不快症状を引き起こす。これにより、皮膚の機能が低下し、さらなるバリア機能の劣化をまねく悪循環に陥る。 The skin layer is a tissue having a thickness of only 20 μm, and has a barrier function to protect the living body from external stimuli such as ultraviolet rays and allergens. When the barrier function of the epidermis layer breaks down, the external stimulus enters the skin and causes symptoms such as rough skin, blemishes, wrinkles, reduced skin, and sagging skin, and itching and inflammation caused by allergen entry. Causes discomfort. As a result, the function of the skin is lowered, resulting in a vicious circle leading to further deterioration of the barrier function.
このバリア機能を増強することにより、皮膚機能の低下を防ぎ、また痒みや炎症などの不快症状を改善することができる。従来、このような問題に対して、特定の植物エキスによる皮膚バリア機能増強剤等が提案されているが、それ自身がアレルゲンとなるといった問題もあり、未だ十分な効果を有するとはいえない。 By enhancing the barrier function, it is possible to prevent a decrease in skin function and to improve unpleasant symptoms such as itching and inflammation. Conventionally, a skin barrier function enhancer or the like by a specific plant extract has been proposed for such a problem, but there is a problem that it itself becomes an allergen, and it cannot be said that it has a sufficient effect.
本発明は、皮膚バリア機能を増強する作用を有する外用組成物を提供することを目的とする。 An object of this invention is to provide the composition for external use which has the effect | action which enhances a skin barrier function.
本発明者らは、上記目的を達成すべく鋭意検討を重ねていたところ、思いがけずも、従来から石鹸として使用されてきた鹸化物に皮膚のバリア機能を増強する作用があることを見出し、さらにこれに高級アルコールを併用することで、上記鹸化物の皮膚バリア機能増強作用がさらに高まり、より一層優れた皮膚バリア機能増強作用を有する組成物が得られることを見出した。 The inventors of the present invention have been diligently studied to achieve the above object, and unexpectedly found that the saponified product conventionally used as soap has an action of enhancing the barrier function of the skin. It has been found that by using a higher alcohol in combination with this, the saponified product has a further enhanced skin barrier function enhancing action, and a composition having an even better skin barrier function enhancing action can be obtained.
本発明はかかる知見に基づいて完成したものであり、下記の実施形態を有するものである。 The present invention has been completed based on this finding, and has the following embodiments.
(I)外用組成物
(I−1)高級脂肪酸、高級脂肪酸塩、及び高級アルコールを含有する外用組成物。
(I−2)高級脂肪酸の含有量が5〜25重量%、高級脂肪酸塩の含有量が2〜10重量%、及び高級アルコールの含有量が0.5〜8重量%である、(I−1)記載の外用組成物。
(I−3)前記高級脂肪酸及び前記高級脂肪酸塩の高級脂肪酸が、それぞれ同一又は異なって、炭素数14〜18の飽和又は不飽和脂肪酸である(I−1)または(I−2)に記載する外用組成物。
(I−4)前記高級アルコールが炭素数14〜18の飽和または不飽和の一価のアルコールである(I−1)〜(I−3)のいずれかに記載する外用組成物。
(I−5)鹸化率が20〜40%、好ましくは30%程度である、(I−1)〜(I−4)のいずれかに記載する外用組成物。
(I−6)さらに液体飽和グリコールを含有する(I−1)〜(I−5)のいずれかに記載する外用組成物。
(I−7)液体飽和グリコールの含有量が0.5〜60重量%である(I−6)に記載する外用組成物。
(I−8)液体飽和グリコールがプロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、及びポリエチレングリコールからなる群から選択される少なくとも1種である、(I−6)または(I−7)のいずれかに記載する外用組成物。
(I−9)O/W型乳化組成物である、(I−1)〜(I−8)のいずれかに記載する外用組成物。
(I−10)化粧料である(I−1)〜(I−9)のいずれかに記載する外用組成物。
(I) External composition (I-1) An external composition containing a higher fatty acid, a higher fatty acid salt, and a higher alcohol.
(I-2) The content of higher fatty acid is 5 to 25% by weight, the content of higher fatty acid salt is 2 to 10% by weight, and the content of higher alcohol is 0.5 to 8% by weight. 1) The composition for external use as described.
(I-3) The higher fatty acid and the higher fatty acid of the higher fatty acid salt are the same or different and are saturated or unsaturated fatty acids having 14 to 18 carbon atoms, as described in (I-1) or (I-2) A composition for external use.
(I-4) The composition for external use according to any one of (I-1) to (I-3), wherein the higher alcohol is a saturated or unsaturated monohydric alcohol having 14 to 18 carbon atoms.
(I-5) The composition for external use according to any one of (I-1) to (I-4), wherein the saponification rate is 20 to 40%, preferably about 30%.
(I-6) The composition for external use described in any one of (I-1) to (I-5), which further contains a liquid saturated glycol.
(I-7) The composition for external use as described in (I-6) whose content of liquid saturated glycol is 0.5 to 60 weight%.
(I-8) The liquid saturated glycol is at least one selected from the group consisting of propylene glycol, dipropylene glycol, 1,3-butylene glycol, and polyethylene glycol, (I-6) or (I-7) The composition for external use described in any one of.
(I-9) The composition for external use described in any one of (I-1) to (I-8), which is an O / W type emulsion composition.
(I-10) The composition for external use described in any one of (I-1) to (I-9), which is a cosmetic.
(II)外用組成物の製造方法
(II−1)原料として少なくとも高級脂肪酸、アルカリ、及び高級アルコールを用いて、これらを混合する工程を有する、(I−1)〜(I−10)のいずれかに記載する外用組成物の製造方法。
(II−2)高級脂肪酸の配合量が8〜30重量%、アルカリの配合量が0.2〜5重量%、及び高級アルコールの含有量が0.5〜8重量%である、(II−1)記載の製造方法。
(II−3)高級脂肪酸の配合量100重量部に対するアルカリの配合量が4〜8重量部である(II−1)または(II−2)に記載する製造方法。
(II−4)前記高級脂肪酸及び前記高級脂肪酸塩の高級脂肪酸が、それぞれ同一又は異なって、炭素数14〜18の飽和又は不飽和の脂肪酸である(II−1)〜(II−3)のいずれかに記載する製造方法。
(II−5)前記高級アルコールが炭素数14〜18の飽和又は不飽和の一価のアルコールである(II−1)〜(II−4)のいずれかに記載する製造方法。
(II−6)鹸化率20〜40%、好ましくは30%程度の外用組成物を製造する方法である(II−1)〜(II−5)のいずれかに記載する製造方法。
(II−7)さらに液体飽和グリコールを配合する工程を有する(II−1)〜(II−6)のいずれかに記載する製造方法。
(II−8)液体飽和グリコールの配合量が0.5〜60重量%である(II−7)に記載する製造方法。
(II−9)液体飽和グリコールがプロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、及びポリエチレングリコールからなる群から選択される少なくとも1種である、(II−7)または(II−8)のいずれかに記載する製造方法。
(II−10)外用組成物がO/W型乳化組成物であって、乳化工程を有する、(II−1)〜(II−9)のいずれかに記載する製造方法。
(II) Method for producing composition for external use (II-1) Any one of (I-1) to (I-10) comprising a step of mixing at least a higher fatty acid, an alkali and a higher alcohol as raw materials A method for producing a composition for external use as described above.
(II-2) The amount of higher fatty acid is 8 to 30% by weight, the amount of alkali is 0.2 to 5% by weight, and the content of higher alcohol is 0.5 to 8% by weight, (II- 1) The manufacturing method as described.
(II-3) The production method according to (II-1) or (II-2), wherein the amount of alkali added is 4 to 8 parts by weight with respect to 100 parts by weight of higher fatty acid.
(II-4) The higher fatty acid and the higher fatty acid of the higher fatty acid salt are the same or different, and are saturated or unsaturated fatty acids having 14 to 18 carbon atoms. (II-1) to (II-3) The manufacturing method described in any one.
(II-5) The production method according to any one of (II-1) to (II-4), wherein the higher alcohol is a saturated or unsaturated monohydric alcohol having 14 to 18 carbon atoms.
(II-6) The production method according to any one of (II-1) to (II-5), which is a method for producing a composition for external use having a saponification rate of 20 to 40%, preferably about 30%.
(II-7) The production method according to any one of (II-1) to (II-6), further comprising a step of blending a liquid saturated glycol.
(II-8) The manufacturing method as described in (II-7) whose compounding quantity of liquid saturated glycol is 0.5 to 60 weight%.
(II-9) The liquid saturated glycol is at least one selected from the group consisting of propylene glycol, dipropylene glycol, 1,3-butylene glycol, and polyethylene glycol, (II-7) or (II-8) The manufacturing method described in any one of.
(II-10) The production method according to any one of (II-1) to (II-9), wherein the external composition is an O / W emulsion composition and has an emulsification step.
(III)美容方法
(III−1)上記(I−1)〜(I−10)のいずれかに記載する外用組成物を、被験者の皮膚に適用する工程を有する、美容方法。
(III−2)上記美容方法が皮膚バリア機能低下に起因する皮膚症状を改善する方法である、(III−1)に記載する美容方法。
(III−3)上記美容方法が肌荒れ、しみ、シワ、ハリの低下、及び肌のたるみからなる群から選択される、皮膚バリア機能低下に起因する皮膚症状を改善する美容方法である、(III−1)または(III−2)に記載する美容方法。
(III) Cosmetic method (III-1) A cosmetic method comprising a step of applying the external composition described in any of (I-1) to (I-10) above to the skin of a subject.
(III-2) The cosmetic method according to (III-1), wherein the cosmetic method is a method for improving skin symptoms caused by a decrease in skin barrier function.
(III-3) The cosmetic method described above is a cosmetic method for improving skin symptoms caused by reduced skin barrier function, selected from the group consisting of rough skin, spots, wrinkles, reduced firmness and sagging skin (III -1) or the cosmetic method described in (III-2).
本発明の外用組成物によれば、皮膚バリア機能が低下した皮膚に適用することで、その機能を改善し向上することができる。その結果、皮膚からの水分蒸散を抑制することができ、肌の保湿性を高め、肌荒れ等の症状を改善することができる。また本発明の皮膚バリア機能増強作用により、アレルゲンや紫外線といった外部刺激の進入を抑制することができ、その結果、シワ(小じわ、大ジワ)、ハリの低下、肌のたるみを抑制し、改善することができ、またアレルゲンなどによる痒みや炎症などの不快症状を軽減させることが可能になる。 According to the composition for external use of the present invention, the function can be improved and improved by applying to the skin having a lowered skin barrier function. As a result, moisture transpiration from the skin can be suppressed, skin moisture retention can be improved, and symptoms such as rough skin can be improved. In addition, the skin barrier function enhancing action of the present invention can suppress the entry of external stimuli such as allergens and ultraviolet rays, thereby suppressing and improving wrinkles (fine wrinkles, large wrinkles), reduction of elasticity and skin sagging. It is also possible to reduce discomfort such as itchiness and inflammation caused by allergens.
(I)外用組成物
本発明の外用組成物は、高級脂肪酸、高級脂肪酸塩、及び高級アルコールを含有することを特徴とする。
(I) External Composition The external composition of the present invention is characterized by containing a higher fatty acid, a higher fatty acid salt, and a higher alcohol.
(A)高級脂肪酸
本発明において、高級脂肪酸は、制限されないものの、炭素数が14〜18の飽和または不飽和脂肪酸であることが好ましい。かかる脂肪酸としては、ミリスチン酸(14:0)、ペンタデシル酸(15:0)、パルミチン酸(16:0)、パルミトレイン酸(16:1)、マルガリン酸(17:0)、ステアリン酸(18:0)、オレイン酸(18:1)、バクセン酸(18:1)、リノール酸(18:2)、リノレン酸(18:3)、及びエレオステアリン酸(18:3)を挙げることができる。なお、上記化学名の後ろの括弧内の数字は前者が脂肪酸の炭素数、後者が二重結合の数を示す。皮膚バリア機能増強作用に加えて、使用感の良さという観点から、より好ましくは炭素数が16〜18の飽和脂肪酸であり、特に好ましくはパルミチン酸、ステアリン酸、マルガリン酸である。
(A) Higher fatty acid In the present invention, the higher fatty acid is not limited, but is preferably a saturated or unsaturated fatty acid having 14 to 18 carbon atoms. Such fatty acids include myristic acid (14: 0), pentadecylic acid (15: 0), palmitic acid (16: 0), palmitoleic acid (16: 1), margaric acid (17: 0), stearic acid (18: 0), oleic acid (18: 1), vaccenic acid (18: 1), linoleic acid (18: 2), linolenic acid (18: 3), and eleostearic acid (18: 3) . The numbers in parentheses after the chemical names indicate the number of carbon atoms of the fatty acid and the latter the number of double bonds. In addition to the skin barrier function enhancing action, from the viewpoint of good usability, a saturated fatty acid having 16 to 18 carbon atoms is more preferable, and palmitic acid, stearic acid, and margaric acid are particularly preferable.
本発明の外用組成物におけるこれらの高級脂肪酸の含有割合は、制限されないものの、通常5〜25重量%程度である。好ましくは7〜20重量%、より好ましくは7〜11重量%である。 Although the content rate of these higher fatty acids in the composition for external use of this invention is not restrict | limited, Usually, it is about 5 to 25 weight%. Preferably it is 7 to 20 weight%, More preferably, it is 7 to 11 weight%.
(B)高級脂肪酸塩
高級脂肪酸塩は、後述するように、製造工程において、原料として使用する高級脂肪酸にアルカリが反応することによって生成されるが、これに限らず、別途添加配合されたものであってもよく、その由来は特に制限されるものではない。
(B) Higher fatty acid salt As described later, higher fatty acid salt is produced by alkali reacting with higher fatty acid used as a raw material in the production process. It may be present and its origin is not particularly limited.
高級脂肪酸塩を構成する高級脂肪酸は、制限されないものの、炭素数が14〜18の飽和または不飽和脂肪酸であることが好ましい。かかる脂肪酸としては、上記高級脂肪酸と同様に、ミリスチン酸(14:0)、ペンタデシル酸(15:0)、パルミチン酸(16:0)、パルミトレイン酸(16:1)、マルガリン酸(17:0)、ステアリン酸(18:0)、オレイン酸(18:1)、バクセン酸(18:1)、リノール酸(18:2)、リノレン酸(18:3)、及びエレオステアリン酸(18:3)を挙げることができる。皮膚バリア機能増強作用に加えて、使用感の良さという観点から、より好ましくは炭素数が16〜18の飽和脂肪酸であり、特に好ましくはパルミチン酸、ステアリン酸、マルガリン酸である。 The higher fatty acid constituting the higher fatty acid salt is not limited, but is preferably a saturated or unsaturated fatty acid having 14 to 18 carbon atoms. Such fatty acids include myristic acid (14: 0), pentadecylic acid (15: 0), palmitic acid (16: 0), palmitoleic acid (16: 1), margaric acid (17: 0), as in the above higher fatty acids. ), Stearic acid (18: 0), oleic acid (18: 1), vaccenic acid (18: 1), linoleic acid (18: 2), linolenic acid (18: 3), and eleostearic acid (18: 3). In addition to the skin barrier function enhancing action, from the viewpoint of good usability, a saturated fatty acid having 16 to 18 carbon atoms is more preferable, and palmitic acid, stearic acid, and margaric acid are particularly preferable.
高級脂肪酸塩としては、上記高級脂肪酸のアルカリ金属塩(脂肪酸ナトリウム、脂肪酸カリウム等)、アルカリ土類金属塩(例えば、脂肪酸マグネシウム、脂肪酸カルシウム、脂肪酸バリウム等)、及びアンモニア塩(脂肪酸アンモニウム)の他、上記高級脂肪酸とアミン類、ヒドロキシルアミン類、イミン類、グアニジン類、アミンオキシド類、アルカノールアミン類、アルコキシル化アミン類、および、アルキルアミン類(ジエタノールアミン、トリエタノールアミン、イソプロパノールアミン、ジイソプロパノールアミン、トリイソプロパノールアミン、アミノブタノール、アミノエチルプロパンジオール、アミノメチルプロパノール、アミノメチルプロパンジオール、イソプロピルアミン、メチルエタノールアミン、ジイソプロピルアミン、ジプロピレントリアミン、グルカミン、N−メチルグルカミン、モルフォリン、トロメタミン)、コカミン類、ソイアミン類、オレアミン類、ステアラミン類、クオテルニウム類などの有機アミンとの反応物を例示することができる。好ましくは脂肪酸のアルカリ金属塩又はアルカリ土類金属塩であり、より好ましくは脂肪酸のアルカリ金属塩である脂肪酸ナトリウム塩、または脂肪酸カリウムである。 Examples of higher fatty acid salts include alkali metal salts (fatty acid sodium, fatty acid potassium, etc.) of the above higher fatty acids, alkaline earth metal salts (eg, fatty acid magnesium, fatty acid calcium, fatty acid barium, etc.), and ammonia salts (fatty acid ammonium). , Higher fatty acids and amines, hydroxylamines, imines, guanidines, amine oxides, alkanolamines, alkoxylated amines, and alkylamines (diethanolamine, triethanolamine, isopropanolamine, diisopropanolamine, Triisopropanolamine, aminobutanol, aminoethylpropanediol, aminomethylpropanol, aminomethylpropanediol, isopropylamine, methylethanolamine, diisopropyl Min, dipropylenetriamine, glucamine, N- methylglucamine, morpholine, tromethamine), cocamine compounds, soyamine acids, oleamine acids, stearamine compounds can be exemplified the reaction product of an organic amine such as Kuoteruniumu class. Preferred are alkali metal salts or alkaline earth metal salts of fatty acids, and more preferred are fatty acid sodium salts or fatty acid potassium which are alkali metal salts of fatty acids.
本発明の外用組成物におけるこれらの高級脂肪酸塩の含有割合は、制限されないものの、通常2〜10重量%程度である。好ましくは2〜9重量%、より好ましくは3〜9重量%である。 Although the content rate of these higher fatty acid salts in the composition for external use of this invention is not restrict | limited, Usually, it is about 2 to 10 weight%. Preferably it is 2-9 weight%, More preferably, it is 3-9 weight%.
(C)高級アルコール
本発明において、高級アルコールは、制限されないものの、炭素数が14〜18の飽和または不飽和の一価のアルコールであることが好ましい。かかる高級アルコールとしては、ミリスチルアルコール、ペンタデシルアルコール、セタノール、セトスアリルアルコール、パルミトレイルアルコール、1−ヘプタデカノール、ステアリルアルコール、イソステアリルアルコール、エライジルアルコール、オレイルアルコール、リノレイルアルコール、リシノレイルアルコール等の脂肪アルコールまたは合成アルコールを挙げることができる。皮膚バリア機能増強作用に加えて、使用感の良さという観点から、好ましくは炭素数が16〜18の飽和の一価アルコールであり、特に好ましくはセタノール、セトスアリルアルコール、パルミトレイルアルコール、1−ヘプタデカノール、ステアリルアルコール、イソステアリルアルコール、オレイルアルコールである。
(C) Higher alcohol In the present invention, the higher alcohol is not limited, but is preferably a saturated or unsaturated monovalent alcohol having 14 to 18 carbon atoms. Such higher alcohols include myristyl alcohol, pentadecyl alcohol, cetanol, cetosallyl alcohol, palmitoleyl alcohol, 1-heptadecanol, stearyl alcohol, isostearyl alcohol, elaidyl alcohol, oleyl alcohol, linoleyl alcohol, and lisinoleyl. Mention may be made of fatty alcohols such as alcohols or synthetic alcohols. From the viewpoint of good usability in addition to the skin barrier function enhancing action, it is preferably a saturated monohydric alcohol having 16 to 18 carbon atoms, particularly preferably cetanol, cetosallyl alcohol, palmitoleyl alcohol, 1-hepta. Decanol, stearyl alcohol, isostearyl alcohol, oleyl alcohol.
本発明の外用組成物におけるこれらの高級アルコールの含有割合は、制限されないものの、通常0.5〜8重量%程度である。好ましくは1〜8重量%、より好ましくは1〜3重量%である。 Although the content rate of these higher alcohols in the composition for external use of this invention is not restrict | limited, Usually, it is about 0.5 to 8 weight%. Preferably it is 1-8 weight%, More preferably, it is 1-3 weight%.
(D)液体飽和グリコール
本発明の外用組成物は、液体飽和グリコールを含有するものであってもよい。当該液体飽和グリコールは、皮膚に対して保湿剤または柔軟剤として作用する。かかる液体飽和グリコールとして、制限されないが、具体的には、プロピレングリコール、ジプロピレングリコール、1,3−ブチレングリコール、及びポリエチレングリコールからなる群から選択される少なくとも1種を挙げることができる。好ましくはプロピレングリコール、ジプロピレングリコール及びポリエチレングリコールであり、より好ましくはプロピレングリコール、ポリエチレングリコールである。本発明の外用組成物における液体飽和グリコールの含有割合として、制限されないものの0.5〜60重量%の範囲を挙げることができる。好ましくは1〜60重量%、より好ましくは5〜60重量%を挙げることができる。
(D) Liquid saturated glycol The composition for external use of the present invention may contain a liquid saturated glycol. The liquid saturated glycol acts as a moisturizer or softener on the skin. Examples of such liquid saturated glycol include, but are not limited to, at least one selected from the group consisting of propylene glycol, dipropylene glycol, 1,3-butylene glycol, and polyethylene glycol. Preferred are propylene glycol, dipropylene glycol and polyethylene glycol, and more preferred are propylene glycol and polyethylene glycol. Although it does not restrict | limit, the range of 0.5 to 60 weight% can be mentioned as content rate of the liquid saturated glycol in the composition for external use of this invention. Preferably 1 to 60 weight%, More preferably, 5 to 60 weight% can be mentioned.
(E)その他の成分
本発明の外用組成物は、皮膚バリア機能増強作用を発揮するという本発明の効果を妨げないことを限度として、上記(A)〜(C)成分、または上記(A)〜(D)成分に加えて、他の成分が含まれていてもよい。かかる成分としては、保湿剤、増粘剤、界面活性剤、油性成分、抗酸化剤、防腐・殺菌剤、粉体成分、香料、顔料、水等を例示することができる。
(E) Other components The above-described components (A) to (C) or the above-mentioned (A), as long as the composition for external use of the present invention does not hinder the effect of the present invention to exert a skin barrier function enhancing action. In addition to the component (D), other components may be contained. Examples of such components include humectants, thickeners, surfactants, oily components, antioxidants, antiseptic / bactericides, powder components, fragrances, pigments, water, and the like.
保湿剤としては、制限されないものの、例えばグリセリン;ソルビトール、キシリトール、及びトレハロースなどの糖類;ピロリドンカルボン酸ナトリウム、乳酸菌発酵米、ヒアルロン酸及びその誘導体(例えば分子量数千から数百万のヒアルロン酸又はその塩類、アセチル化ヒアルロン酸、ヒアルロン酸プロピレングリコール、ヒアルロン酸ヒドロキシプロピルトリモニウムなど)、ムコ多糖類(例えばコンドロイチン及びその誘導体、ヘパリン及びその誘導体など)、エラスチン及びその誘導体、コラーゲン及びその誘導体、加水分解シルク蛋白質、乳酸、尿素、高級脂肪酸オクチルドデシル、フィトステロール、大豆リン脂質、イソステアリン酸コレステリル、海藻抽出物、魚介類由来コラーゲン及びその誘導体、各種アミノ酸及びそれらの誘導体(例えばトリメチルグリシンなど)、ヘチマ抽出物、ビャッキュウ抽出物、豆乳発酵液、納豆エキス、米由来抽出物及びその発酵物などが挙げられる。 Examples of humectants include, but are not limited to, glycerin; saccharides such as sorbitol, xylitol, and trehalose; sodium pyrrolidonecarboxylate, lactic acid bacteria fermented rice, hyaluronic acid and its derivatives (for example, hyaluronic acid having a molecular weight of several thousand to several million or its Salts, acetylated hyaluronic acid, propylene glycol hyaluronate, hydroxypropyltrimonium hyaluronate), mucopolysaccharides (eg chondroitin and its derivatives, heparin and its derivatives), elastin and its derivatives, collagen and its derivatives, hydrolysis Silk protein, lactic acid, urea, higher fatty acid octyldodecyl, phytosterol, soybean phospholipid, cholesteryl isostearate, seaweed extract, collagen derived from seafood and its derivatives, various amino acids and their Et derivatives (such as trimethyl glycine, etc.), luffa extract, Byakkyuu extract, soybean milk fermented liquor, natto extract, and the like rice-derived extract and fermented product.
増粘剤としては、制限されないものの、例えばアルギン酸、寒天、カラギーナン、フコイダンなどの褐藻、緑藻或いは紅藻由来成分;ビャッキュウ抽出物、ペクチン、ローカストビーンガム、アロエ多糖体などの多糖類;キサンタンガム、トラガントガム、グアーガムなどのガム類;カルボキシメチルセルロース、ヒドロキシエチルセルロースなどのセルロース誘導体;ポリビニルアルコール、ポリビニルピロリドン、カルボキシビニルポリマー、アクリル酸・メタクリル酸共重合体などの合成高分子類;ポリグルタミン酸及びその誘導体;グルコシルトレハロースと加水分解水添澱粉を主体とする糖化合物などが挙げられる。 Thickeners are not limited, but include, for example, components derived from brown algae, green algae, or red algae such as alginic acid, agar, carrageenan, and fucoidan; polysaccharides such as beech extract, pectin, locust bean gum, aloe polysaccharide; xanthan gum, tragacanth gum Gums such as guar gum; cellulose derivatives such as carboxymethyl cellulose and hydroxyethyl cellulose; synthetic polymers such as polyvinyl alcohol, polyvinyl pyrrolidone, carboxyvinyl polymer, acrylic acid / methacrylic acid copolymer; polyglutamic acid and its derivatives; glucosyl trehalose And sugar compounds mainly composed of hydrolyzed hydrogenated starch.
界面活性剤としては、制限されないものの、例えばポリオキシエチレンアルキルエーテル、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル、グリセリン脂肪酸エステル、ポリグリセリン脂肪酸エステル、ポリオキシエチレングリセリン脂肪酸エステル、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビトール脂肪酸エステルなどの非イオン界面活性剤;脂肪酸塩、アルキル硫酸塩、アルキルベンゼンスルホン酸塩、ポリオキシエチレンアルキルエーテル硫酸塩、ポリオキシエチレン脂肪アミン硫酸塩、ポリオキシエチレンアルキルフェニルエーテル硫酸塩、ポリオキシエチレンアルキルエーテル燐酸塩、α−スルホン化脂肪酸アルキルエステル塩、ポリオキシエチレンアルキルフェニルエーテル燐酸塩などのアニオン界面活性剤;第四級アンモニウム塩、第一級〜第三級脂肪族アミン塩、トリアルキルベンジルアンモニウム塩、アルキルピリジニウム塩、2−アルキル−1−アルキル−1−ヒドロキシエチルイミダゾリニウム塩、N,N−ジアルキルモルフォルニウム塩、ポリエチレンポリアミン脂肪酸アミド塩などのカチオン界面活性剤;N,N−ジメチル−N−アルキル−N−カルボキシメチルアンモニオベタイン、N,N,N−トリアルキル−N−アルキレンアンモニオカルボキシベタイン、N−アシルアミドプロピル−N′,N′−ジメチル−N′−β−ヒドロキシプロピルアンモニオスルホベタインなどの両性界面活性剤などを挙げることができる。また、乳化剤または乳化助剤として、酵素処理ステビアなどのステビア誘導体、レシチン及びその誘導体、乳酸菌発酵米、乳酸菌発酵発芽米、乳酸菌発酵穀類(麦類、豆類、雑穀など)、ビャッキュウ抽出物などを配合することもできる。 The surfactant is not limited, but for example, polyoxyethylene alkyl ether, polyoxyethylene fatty acid ester, polyoxyethylene sorbitan fatty acid ester, glycerin fatty acid ester, polyglycerin fatty acid ester, polyoxyethylene glycerin fatty acid ester, polyoxyethylene cured Nonionic surfactants such as castor oil and polyoxyethylene sorbitol fatty acid ester; fatty acid salt, alkyl sulfate, alkylbenzene sulfonate, polyoxyethylene alkyl ether sulfate, polyoxyethylene fatty amine sulfate, polyoxyethylene alkylphenyl Ether sulfate, polyoxyethylene alkyl ether phosphate, α-sulfonated fatty acid alkyl ester salt, polyoxyethylene alkyl phenyl ether Anionic surfactants such as ruphosphates; quaternary ammonium salts, primary to tertiary aliphatic amine salts, trialkylbenzylammonium salts, alkylpyridinium salts, 2-alkyl-1-alkyl-1-hydroxyethyls Cationic surfactants such as imidazolinium salt, N, N-dialkylmorphonium salt, polyethylene polyamine fatty acid amide salt; N, N-dimethyl-N-alkyl-N-carboxymethylammoniobetaine, N, N, N And amphoteric surfactants such as -trialkyl-N-alkyleneammoniocarboxybetaine and N-acylamidopropyl-N ', N'-dimethyl-N'-β-hydroxypropylammoniosulfobetaine. In addition, stevia derivatives such as enzyme-treated stevia, lecithin and its derivatives, lactic acid bacteria fermented rice, lactic acid bacteria fermented germinated rice, lactic acid bacteria fermented cereals (wheat, beans, millet, etc.), beech extract etc. You can also
油性成分としては、制限されないものの、流動パラフィン、ワセリン、パラフィンワックス、スクワランなどの炭化水素類;などが挙げられる。 Examples of the oil component include, but are not limited to, hydrocarbons such as liquid paraffin, petrolatum, paraffin wax, and squalane.
抗酸化剤としては、制限されないが、例えばブチルヒドロキシアニソール、ブチルヒドロキシトルエン、没食子酸プロピル、ビタミンE及びその誘導体、ビタミンC(アスコルビン酸)及びその誘導体、ユビデカキノン(ユビキノン)、ルチン、ルチングルコシド、白芥子抽出物、イネ抽出物、ムラサキシキブ抽出物、シラカバ抽出物、ハマメリス抽出物、ウーロン茶抽出物、黒豆加水分解抽出液、シャクヤク抽出物、ビャッキュウ抽出物、ハゴロモグサ抽出液などが挙げられる。 Antioxidants include, but are not limited to, for example, butylhydroxyanisole, butylhydroxytoluene, propyl gallate, vitamin E and its derivatives, vitamin C (ascorbic acid) and its derivatives, ubidecaquinone (ubiquinone), rutin, rutin glucoside, white Examples of the extract include a coconut extract, a rice extract, a purple extract, a birch extract, a hamamelis extract, a oolong tea extract, a black bean hydrolyzed extract, a peony extract, a beech cucumber extract, and a sorghum extract.
防腐・殺菌剤としては、制限されないが、例えば尿素、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸プロピル、パラオキシ安息香酸ブチルなどのパラオキシ安息香酸エステル類、フェノキシエタノール、ジクロロフェン、ヘキサクロロフェン、塩酸クロルヘキシジン、塩化ベンザルコニウム、サリチル酸、エタノール、ウンデシレン酸、フェノール類、ジャマール(イミダゾデイニールウレア)、樹皮乾留物、プロポリスエキス、メチルイソチアゾリノンなどを挙げることができる。 Examples of the antiseptic / bactericidal agent include, but are not limited to, paraoxybenzoates such as urea, methyl paraoxybenzoate, ethyl paraoxybenzoate, propyl paraoxybenzoate, and butyl paraoxybenzoate, phenoxyethanol, dichlorophene, hexachlorophene, hydrochloric acid Examples include chlorhexidine, benzalkonium chloride, salicylic acid, ethanol, undecylenic acid, phenols, jamal (imidazolidene urea), dry bark, propolis extract, and methylisothiazolinone.
粉体成分としては、制限されないものの、例えばセリサイト、酸化チタン、タルク、カオリン、ベントナイト、酸化亜鉛、炭酸マグネシウム、酸化マグネシウム、酸化ジルコニウム、硫酸バリウム、無水ケイ酸、雲母、6−又は12−ナイロンパウダー、ポリエチレンパウダー、シルクパウダー、セルロース系パウダー、穀類(米、麦、トウモロコシ、キビなど)のパウダー、豆類(大豆、小豆など)のパウダーなどがある。 Examples of powder components include, but are not limited to, sericite, titanium oxide, talc, kaolin, bentonite, zinc oxide, magnesium carbonate, magnesium oxide, zirconium oxide, barium sulfate, silicic anhydride, mica, 6- or 12-nylon. There are powder, polyethylene powder, silk powder, cellulosic powder, powder of cereals (rice, wheat, corn, millet, etc.), powder of beans (soybean, red beans, etc.).
さらに必要に応じて、本発明の効果を妨げない範囲で、他の生理活性成分(線維芽細胞賦活剤、美白剤、皮膚老化防止・肌荒れ改善剤など)を配合してもよい。 Further, if necessary, other physiologically active ingredients (fibroblast activator, whitening agent, skin aging prevention / roughness improving agent, etc.) may be blended within a range not impeding the effects of the present invention.
線維芽細胞賦活剤としては、制限はされないが、例えばビルベリー葉エキス、ポリアミン、アロエエキス、カッコンエキス、クロレラエキス、プラセンタエキス、サトウカエデ樹液、ローヤルゼリー、酵母エキス、ムコ多糖体液、ヒオウギ抽出液、ダイズエキス、ホエイなどを挙げることができる。 The fibroblast activator is not limited, but for example, bilberry leaf extract, polyamine, aloe extract, cuckoo extract, chlorella extract, placenta extract, sugar maple tree sap, royal jelly, yeast extract, mucopolysaccharide fluid, dairy extract, soybean extract, Whey etc. can be mentioned.
美白剤としては、制限されないが、例えばt−シクロアミノ酸誘導体、コウジ酸及びその誘導体、ビタミンC(アスコルビン酸)及びその誘導体、ハイドロキノン又はその誘導体、エラグ酸及びその誘導体、ニコチン酸及びその誘導体、レゾルシノール誘導体、トラネキサム酸及びその誘導体、4−メトキシサリチル酸カリウム塩、マグノリグナン(5,5'−ジプロピル−ビフェニル−2,2’−ジオール)、4−HPB(ロドデノール、4−(4−ヒドロキシフェニル)−4−ブタノール))、ヒドロキシ安息香酸及びその誘導体、ビタミンE及びその誘導体、α−ヒドロキシ酸、AMP(アデノシンモノホスフェイト、アデノシン1リン酸)、胎盤抽出液、ソウハクヒ抽出物、ユキノシタ抽出物、米糠抽出物又はその加水分解物、白芥子抽出物又はその加水分解物、白芥子の発酵物、シャクヤク抽出物又はその加水分解物、乳酸菌醗酵米、乳酸菌醗酵発芽米、乳酸菌醗酵穀類(麦類、豆類、雑穀類)、ムラサキシキブ抽出物、ハス種子抽出物又はその加水分解物、ハス種子発酵物、党参抽出物、ハトムギ加水分解物、ハトムギ種子発酵物、ローヤルゼリー発酵物、酒粕発酵物、パンダヌス・アマリリフォリウス(Pandanus amaryllifolius Roxb.)抽出物、アルカンジェリシア・フラバ(Arcangelicia flava Merrilli)抽出物、カミツレ抽出物等を挙げることができる。 Examples of the whitening agent include, but are not limited to, t-cycloamino acid derivatives, kojic acid and its derivatives, vitamin C (ascorbic acid) and its derivatives, hydroquinone or its derivatives, ellagic acid and its derivatives, nicotinic acid and its derivatives, resorcinol Derivatives, tranexamic acid and derivatives thereof, 4-methoxysalicylic acid potassium salt, magnolignan (5,5'-dipropyl-biphenyl-2,2'-diol), 4-HPB (rhodenol, 4- (4-hydroxyphenyl)- 4-butanol)), hydroxybenzoic acid and its derivatives, vitamin E and its derivatives, α-hydroxy acid, AMP (adenosine monophosphate, adenosine monophosphate), placenta extract, suha akuhi extract, yukinoshita extract, rice bran Extract or its hydrolyzate, white coconut extract Or hydrolyzate thereof, fermented white coconut, peony extract or hydrolyzate thereof, lactic acid bacteria fermented rice, lactic acid bacteria fermented rice, lactic acid bacteria fermented cereals (wheat, legumes, millet), murasakixikibu extract, lotus seed extract Or hydrolyzate thereof, fermented lotus seed, extract of party ginseng, pearl hydrolyzate, fermented pearl seed, fermented royal jelly, fermented sake lees, Pandanus amaryllifolius Roxb. Examples thereof include an extract of a sea flava (Arcangelicia flava Merrilli) and a chamomile extract.
皮膚老化防止・肌荒れ改善成分としては、制限されないが、例えばサンゴ草抽出物、イネの葉の抽出物又はその加水分解物、ナス(水ナス、長ナス、賀茂ナス、米ナス等)抽出物又はその加水分解物、カタメンキリンサイ等の海藻の抽出物、アマモ等の海産顕花植物の抽出物、クラゲ水、米抽出物又はその加水分解物、米醗酵エキス、発芽米抽出物又はその加水分解物、発芽米発酵物、黒豆抽出物又はその加水分解物、動物又は魚由来のコラーゲン及びその誘導体、エラスチン及びその誘導体、セラミドなどの細胞間脂質、グリチルリチン酸及びその誘導体(ジカリウム塩等)、t−シクロアミノ酸誘導体、ビタミンA及びその誘導体、t−シクロアミノ酸誘導体、ビタミンA及びその誘導体、ビタミンE及びその誘導体(d,l−α−トコフェリルリン酸ナトリウムなど)、アラントイン、α−ヒドロキシ酸類、ジイソプロピルアミンジクロロアセテート、γ−アミノ−β−ヒドロキシ酪酸、コエンザイムQ−10、α−リポ酸、エルゴチオネイン、アラントイン、ジイソプロピルアミンジクロロアセテート、γ−アミノ−β−ヒドロキシ酪酸、ゲンチアナ抽出物、甘草抽出物、ニンジン抽出物、アロエ抽出物、ミツイシコンブ抽出物、アナアオサ抽出物、ジュアゼイロ(Zizyphus joazeiro)抽出物、ブナ抽出物、キダチアロエ抽出物、マンネンロウ抽出物、イチョウ抽出物、スギナ抽出物、ベニバナ抽出物、オタネニンジン抽出物、セイヨウニワトコ抽出物、ハゴロモグサ抽出物、レンゲ抽出物、マンゴー抽出物、チェリモヤ抽出物、マンゴスチン抽出物、タベブイア・インペティギノーサ抽出物、酵母抽出物、卵殻膜抽出蛋白質、デオキシリボ核酸カリウム塩、ハス種子発酵液、花粉荷エキスなどが挙げられる。 The skin aging prevention / roughness improving component is not limited, for example, coral grass extract, rice leaf extract or hydrolyzate thereof, eggplant (water eggplant, long eggplant, Kamo eggplant, rice eggplant etc.) extract or Hydrolyzate thereof, extract of seaweed such as catamen giraffe, extract of marine flowering plant such as sea eel, jellyfish water, rice extract or hydrolyzate thereof, rice fermentation extract, germinated rice extract or hydrolyzate thereof Germinated rice fermented product, black bean extract or hydrolyzate thereof, collagen derived from animal or fish and derivatives thereof, elastin and derivatives thereof, intercellular lipids such as ceramide, glycyrrhizic acid and derivatives thereof (dipotassium salt, etc.), t- Cycloamino acid derivative, vitamin A and its derivative, t-cycloamino acid derivative, vitamin A and its derivative, vitamin E and its derivative (d, l-α-toco Sodium eryl phosphate), allantoin, α-hydroxy acids, diisopropylamine dichloroacetate, γ-amino-β-hydroxybutyric acid, coenzyme Q-10, α-lipoic acid, ergothioneine, allantoin, diisopropylamine dichloroacetate, γ-amino- β-hydroxybutyric acid, gentian extract, licorice extract, carrot extract, aloe extract, beetle extract, anaosa extract, zizyphus joazeiro extract, beech extract, beetle aloe extract, mannenrou extract, ginkgo biloba Extract, Horsetail extract, Safflower extract, Panax ginseng extract, Horseshoe extract, Jasmine extract, Astragalus extract, Mango extract, Cherimoya extract, Mangosteen extract, Tabebuia impetigenosa Extracts, yeast extract, eggshell membrane extract protein, deoxyribonucleic acid potassium salt, lotus seed fermented liquid, pollen cargo extract and the like can be mentioned.
本発明の外用組成物は、後述するように、原料として高級脂肪酸とアルカリを用いて製造され、その結果、高級脂肪酸の一部が鹸化された状態で含むものである。かかる本発明の外用組成物の鹸化率としては、制限されないものの20〜40%の範囲を挙げることができる。好ましくは20〜35%であり、より好ましくは25〜35%、特に好ましくは30%程度である。 As will be described later, the composition for external use of the present invention is produced using a higher fatty acid and an alkali as raw materials, and as a result, contains a part of the higher fatty acid in a saponified state. The saponification rate of the composition for external use of the present invention is not limited, but can be in the range of 20 to 40%. Preferably it is 20 to 35%, more preferably 25 to 35%, particularly preferably about 30%.
本発明の外用組成物は、上記(A)〜(C)成分、また必要に応じて(D)成分、及び/または(E)成分を配合混合して、所望の形状(固形状、半固形状[ゲル状、クリーム状、軟膏状等]、液体[乳液状、ローション状等])に調製することができる。好ましくは乳化物、特にO/W型の乳化物であり、より好ましくはクリーム状の外用組成物として調製することができる。当該外用組成物は、医薬品、医薬部外品、及び化粧品のいずれの範疇に含まれるものであってもよい。好ましくは外用の医薬部外品、及び化粧品であり、より好ましくは化粧品である。 The composition for external use of the present invention comprises the above components (A) to (C) and, if necessary, the component (D) and / or the component (E), and is mixed into a desired shape (solid, semi-solid). Shapes [gels, creams, ointments, etc.] and liquids [emulsions, lotions, etc.]). An emulsion, particularly an O / W emulsion, is preferred, and a creamy external composition can be more preferably prepared. The external composition may be included in any category of pharmaceuticals, quasi drugs, and cosmetics. Preferred are quasi-drugs for external use and cosmetics, and more preferred are cosmetics.
外用の医薬品または医薬部外品としての形態としては、制限されないものの、例えばクリーム剤、軟膏剤、硬膏剤、パップ剤、ローション剤、乳液剤、液剤、エアゾール剤等を挙げることができる。好ましくはクリーム剤、及び乳液剤である。化粧品としての形態としては、制限されないものの、例えばスキンケア化粧品として、化粧水、美容液、パック、マッサージクリーム、乳液、モイスチャークリーム、バニシングクリーム、クレンジングクリーム、リップクリーム等を挙げることができる。好ましくはマッサージクリーム、乳液、モイスチャークリーム、バニシングクリーム、クレンジングクリームである。 Although it does not restrict | limit as a form as a pharmaceutical for external use or a quasi-drug, For example, a cream, an ointment, a plaster, a poultice, a lotion, an emulsion, a liquid, an aerosol, etc. can be mentioned. Creams and emulsions are preferred. Although it does not restrict | limit as a form as cosmetics, For example, as a skin care cosmetics, a lotion, a cosmetic liquid, a pack, a massage cream, an emulsion, a moisture cream, a vanishing cream, a cleansing cream, a lip balm etc. can be mentioned. Massage cream, milky lotion, moisture cream, burnishing cream and cleansing cream are preferred.
(II)外用組成物の製造方法
前述する少なくとも(A)〜(C)成分を含有する本発明の外用組成物は、原料として少なくとも高級脂肪酸、アルカリ、及び高級アルコールを用いて、これらを混合する工程を経て調製することができる。
(II) Manufacturing method of composition for external use The composition for external use of the present invention containing at least the components (A) to (C) described above mixes at least higher fatty acids, alkalis and higher alcohols as raw materials. It can be prepared through a process.
ここで使用される高級脂肪酸及び高級アルコールの種類は、上記(I)に記載の通りであり、上記記載を援用することができる。 The kind of higher fatty acid and higher alcohol used here is as described in the above (I), and the above description can be used.
製造に使用する高級脂肪酸の量としては、調製後の外用組成物中に含まれる高級脂肪酸の割合が前述するように、通常5〜25重量%程度、好ましくは7〜20重量%、より好ましくは7〜11重量%となり、その場合の鹸化率が20〜40%、好ましくは20〜35%であり、より好ましくは25〜35%となるような割合であればよく、その限りにおいて特に制限されるものではない。製造原料の総量を100重量%とした場合に、使用する高級脂肪酸の割合として通常8〜30重量%を挙げることができる。好ましくは10〜30重量%であり、より好ましくは10〜15重量%である。 As the amount of the higher fatty acid used in the production, as described above, the proportion of the higher fatty acid contained in the external composition after preparation is usually about 5 to 25% by weight, preferably 7 to 20% by weight, more preferably The ratio is 7 to 11% by weight, and the saponification ratio in that case is 20 to 40%, preferably 20 to 35%, more preferably 25 to 35%. It is not something. When the total amount of production raw materials is 100% by weight, the proportion of higher fatty acids used can usually be 8 to 30% by weight. Preferably it is 10-30 weight%, More preferably, it is 10-15 weight%.
製造に使用する高級アルコールの量としては、制限されないものの、製造原料の総量を100重量%とした場合に、(I)に記載されるように、通常0.5〜8重量%程度を挙げることができる。好ましくは1〜8重量%、より好ましくは1〜3重量%である。 The amount of higher alcohol used in the production is not limited, but when the total amount of production raw materials is 100% by weight, usually about 0.5 to 8% by weight is mentioned as described in (I). Can do. Preferably it is 1-8 weight%, More preferably, it is 1-3 weight%.
また製造に使用するアルカリは、水溶液とした場合にpH7以上を示す物質であり、上記高級脂肪酸と反応して鹸化物として、前述する高級脂肪酸塩を生成する物質である。 The alkali used for the production is a substance that exhibits a pH of 7 or more when it is made into an aqueous solution, and is a substance that reacts with the higher fatty acid to produce the above-mentioned higher fatty acid salt as a saponified product.
当該アルカリには、無機アルカリと有機アルカリのいずれもが含まれる。無機アルカリとしては、例えば、アルカリ金属又はアルカリ土類金属の水酸化物塩(例えば、水酸化ナトリウム、水酸化カリウム、水酸化マグネシウム、水酸化カルシウム等)、アルカリ金属の炭酸塩または重炭酸塩(例えば、炭酸ナトリウム、重炭酸ナトリウム、炭酸カリウム、重炭酸カリウム)、アルカリ金属のリン酸塩(例えば、リン酸ナトリウム、リン酸カリウム)、アンモニアの無機塩(例えば水酸化アンモニウム、リン酸アンモニウム、炭酸または重炭酸アンモニウム)等を挙げることができる。有機アルカリとしては、例えばアミン類、ヒドロキシルアミン類、イミン類、グアニジン類、アミンオキシド類、アルカノールアミン類、アルコキシル化アミン類、および、アルキルアミン類(ジエタノールアミン、トリエタノールアミン、イソプロパノールアミン、ジイソプロパノールアミン、トリイソプロパノールアミン、アミノブタノール、アミノエチルプロパンジオール、アミノメチルプロパノール、アミノメチルプロパンジオール、イソプロピルアミン、メチルエタノールアミン、ジイソプロピルアミン、ジプロピレントリアミン、グルカミン、N−メチルグルカミン、モルフォリン、トロメタミン)、コカミン類、ソイアミン類、オレアミン類、ステアラミン類、クオテルニウム類などを例示することができる。好ましくは無機のアルカリである。より好ましくはアルカリ金属又はアルカリ土類金属の水酸化物塩、アルカリ金属の炭酸塩、重炭酸塩、またはリン酸塩であり、アルカリ金属の水酸化物塩が特に好ましい。 The alkali includes both inorganic alkalis and organic alkalis. Examples of the inorganic alkali include alkali metal or alkaline earth metal hydroxide salts (for example, sodium hydroxide, potassium hydroxide, magnesium hydroxide, calcium hydroxide, etc.), alkali metal carbonates or bicarbonates ( For example, sodium carbonate, sodium bicarbonate, potassium carbonate, potassium bicarbonate), alkali metal phosphates (eg, sodium phosphate, potassium phosphate), ammonia inorganic salts (eg, ammonium hydroxide, ammonium phosphate, carbonic acid) Or ammonium bicarbonate). Examples of the organic alkali include amines, hydroxylamines, imines, guanidines, amine oxides, alkanolamines, alkoxylated amines, and alkylamines (diethanolamine, triethanolamine, isopropanolamine, diisopropanolamine). , Triisopropanolamine, aminobutanol, aminoethylpropanediol, aminomethylpropanol, aminomethylpropanediol, isopropylamine, methylethanolamine, diisopropylamine, dipropylenetriamine, glucamine, N-methylglucamine, morpholine, tromethamine), Examples include cocamines, soiamines, oleamines, stearamines, quaterniums and the like. An inorganic alkali is preferable. More preferred are alkali metal or alkaline earth metal hydroxide salts, alkali metal carbonates, bicarbonates, or phosphates, with alkali metal hydroxide salts being particularly preferred.
製造に使用するアルカリの量として、制限されないものの、製造原料の総量を100重量%とした場合に、通常0.5〜5重量%程度を挙げることができる。好ましくは0.5〜2重量%であり、より好ましくは0.6〜2重量%である。 Although it does not restrict | limit as an amount of the alkali used for manufacture, When the total amount of a manufacturing raw material is 100 weight%, about 0.5 to 5 weight% can be mentioned normally. Preferably it is 0.5 to 2 weight%, More preferably, it is 0.6 to 2 weight%.
また製造原料として使用する前記高級脂肪酸100重量部に対する上記アルカリの割合として、制限されないものの、鹸化率が20〜40%、好ましくは20〜35%であり、より好ましくは25〜35%となるような割合を挙げることができ、この限りにおいて制限されないものの、具体的には例えば0.5〜5重量部、好ましくは0.5〜2重量部、より好ましくは0.6〜2重量部を挙げることができる。 Further, the ratio of the alkali to 100 parts by weight of the higher fatty acid used as a production raw material is not limited, but the saponification rate is 20 to 40%, preferably 20 to 35%, more preferably 25 to 35%. Although it is not limited as long as it is limited, specifically 0.5 to 5 parts by weight, preferably 0.5 to 2 parts by weight, and more preferably 0.6 to 2 parts by weight. be able to.
さらに本発明の外用組成物が他成分として液体飽和グリコール及び/又はその他の任意成分を含有する場合、本発明の外用組成物は上記成分に加えて、液体飽和グリコール及び/又はその他の任意成分を配合することで製造される。液体飽和グリコールの種類は前述した通りであり、その量は製造原料の総量を100重量%とした場合に、通常0.5〜60重量%程度を挙げることができる。好ましくは1〜60重量%であり、より好ましくは5〜60重量%である。 Furthermore, when the composition for external use of the present invention contains liquid saturated glycol and / or other optional components as other components, the composition for external use of the present invention contains liquid saturated glycol and / or other optional components in addition to the above components. Manufactured by blending. The type of the liquid saturated glycol is as described above, and the amount thereof can usually be about 0.5 to 60% by weight when the total amount of the raw materials for production is 100% by weight. Preferably it is 1 to 60 weight%, More preferably, it is 5 to 60 weight%.
本発明の製造方法は、基本的には前述するように上記成分を原料として用いて、これらを配合し混合する工程を有するものであるが、より具体的には、製造する外用組成物の形状(固形状、液状、半固形状)、製剤形状(クリーム、軟膏、硬膏、パップ、ローション、乳液、液剤、エアゾール)、並びにその用途(医薬品、医薬部外品、及び化粧品)に応じて、その定法に従って実施することができる。本発明の外用組成物の好ましい態様は乳化物、より好ましくはクリーム状、特にO/W型クリームの外用組成物であることから、好ましくは、乳化物、より好ましくはクリーム状、特にO/W型クリームの製造方法に従って、乳化工程を経て調製することができる。 The production method of the present invention basically has a step of blending and mixing the above components as raw materials as described above, more specifically, the shape of the composition for external use to be produced. (Solid, liquid, semi-solid), formulation (cream, ointment, plaster, pap, lotion, emulsion, liquid, aerosol) and its use (pharmaceuticals, quasi drugs and cosmetics) It can be carried out according to standard methods. A preferred embodiment of the composition for external use of the present invention is an emulsion, more preferably a cream-like, particularly an O / W-type cream external-use composition, and therefore preferably an emulsion, more preferably a cream-like, especially O / W. According to the manufacturing method of a type cream, it can prepare through an emulsification process.
乳化工程は、原料を所定の温度になるように加熱した後に、ホモジナイザー、ホモミキサー、攪拌機等の混合機を用いて所定条件で乳化する等、定法に従って実施することができる。 The emulsification step can be carried out according to a conventional method such as heating the raw material to a predetermined temperature and then emulsifying under a predetermined condition using a mixer such as a homogenizer, a homomixer, or a stirrer.
(III)美容方法
本発明は、皮膚バリア機能が低下した被験者に対して、前述する本発明の外用組成物を適用し、当該被験者の皮膚バリア機能を増強し改善する美容方法に関する。なお、本発明が対象とする方法は、美容方法であり、ヒトに対する治療方法ではない。
(III) Cosmetic method The present invention relates to a cosmetic method in which the above-described external composition of the present invention is applied to a subject having a reduced skin barrier function to enhance and improve the subject's skin barrier function. Note that the method targeted by the present invention is a cosmetic method, not a treatment method for humans.
皮膚バリア機能低下の原因は特に制限されないが、例えば加齢または紫外線照射を挙げることができる。加齢または紫外線照射によって皮膚バリア機能が低下することで、肌水分蒸散量(TEWL)が増え、肌乾燥、シワ(乾燥シワ、真皮シワ)、肌のたるみ及びハリ低下等の肌劣化症状を引導する。 Although the cause in particular of a skin barrier function fall is not restrict | limited, For example, aging or ultraviolet irradiation can be mentioned. Decreased skin barrier function due to aging or UV irradiation increases skin moisture transpiration (TEWL), leading to skin deterioration symptoms such as skin dryness, wrinkles (dry wrinkles, dermis wrinkles), sagging skin and reduced firmness. To do.
対象とする被験者は、皮膚バリア機能が低下しているか低下が疑われる者であればよく、特に制限されないものの、好適には加齢または紫外線照射による肌劣化症状を有する者、好ましくは加齢による肌劣化症状(肌老化症状)を有する者である。通常、男女ともに30歳を超えると当該該当の被験者になる可能性がある。好ましくは40歳以上、より好ましくは45歳以上、さらに好ましくは50歳以上である。 The subject is not limited as long as the skin barrier function is lowered or suspected to be lowered, and preferably is a person having symptoms of skin deterioration due to aging or ultraviolet irradiation, preferably due to aging Those who have skin deterioration symptoms (skin aging symptoms). In general, if both men and women are over 30 years old, there is a possibility of becoming the subject concerned. Preferably it is 40 years old or more, More preferably, it is 45 years old or more, More preferably, it is 50 years old or more.
本発明の外用組成物は、その形態によっても異なるが、硬膏、軟膏、クリーム、リニメント、ローション、乳液、液、エアゾール等の形態を有する場合、当該外用の医薬品、医薬部外品及び化粧品を被験者の所望の部位の皮膚に塗布または噴霧することによって使用することができる。また外用の医薬品、医薬部外品及び化粧品がパップ剤の形態を有する場合、当該外用の医薬品、医薬部外品及び化粧品を被験者の所望の部位の皮膚に貼付することによって使用することができる。皮膚への適用は、1日1回または複数回行ってよく、例えば朝と晩(寝る前)に適用する方法を挙げることができる。斯くして加齢または紫外線照射等によって皮膚のバリア機能の低下に伴う肌劣化症状(特に肌老化症状)の発生を抑制し(予防)、また改善することが可能になる。 The composition for external use of the present invention varies depending on its form, but when it has a form such as a plaster, ointment, cream, liniment, lotion, milky lotion, liquid, aerosol, etc., the topical pharmaceuticals, quasi drugs and cosmetics are subjects. Can be used by applying or spraying to the skin of the desired site. Moreover, when external medicine, a quasi-drug, and cosmetics have the form of a poultice, it can be used by sticking the external medicine, a quasi-drug, and a cosmetic to the skin of a desired part of a subject. Application to the skin may be performed once or a plurality of times a day, and examples thereof include a method of applying in the morning and evening (before going to bed). Thus, it is possible to suppress (prevent) or improve the occurrence of skin deterioration symptoms (particularly skin aging symptoms) associated with a decrease in the skin barrier function by aging or ultraviolet irradiation.
以下、本発明を実験例及び実施例に基づいて説明する。但し、当該実験例及び実施例は、本発明の一例であり、本発明はこれらの実験例や実施例に制限されるものではない。 Hereinafter, the present invention will be described based on experimental examples and examples. However, the experimental examples and examples are examples of the present invention, and the present invention is not limited to these experimental examples and examples.
実験例1 経上皮水分蒸散量(TEWL)の評価
表2に示す組成からなる皮膚外用組成物(クリーム剤)(実施例1〜4、比較例1)をヒトの皮膚に適用して経上皮水分蒸散量を測定し、皮膚バリア機能増強作用を評価した。
Experimental Example 1 Evaluation of Transepithelial Water Evaporation (TEWL) Transepithelial moisture by applying a composition for external use on skin (cream) (Examples 1 to 4 and Comparative Example 1) having the composition shown in Table 2 to human skin The amount of transpiration was measured, and the skin barrier function enhancing action was evaluated.
(1)被験試料(皮膚外用剤)の調製
表2に記載する組成について、実施例1〜4については、まず表1記載のA相の成分を表1記載の割合でとり80℃に加熱する。次いでB相の成分を表1記載の割合でとり80℃に加熱する。次いでA相成分の混合物にB相成分の混合物を加えて攪拌する。次いでこれを30℃まで冷却(自然放冷)しながら攪拌して表2に記載の組成からなる乳化物(クリーム状)(被験試料(皮膚外用組成物))を調製した。
(1) Preparation of test sample (external preparation for skin) Regarding the compositions described in Table 2, for Examples 1 to 4, first, the components of Phase A described in Table 1 are taken at the ratio described in Table 1 and heated to 80 ° C. . Next, the components of phase B are taken at the ratios shown in Table 1 and heated to 80 ° C. Next, the B phase component mixture is added to the A phase component mixture and stirred. Next, this was stirred while cooling to 30 ° C. (natural cooling) to prepare an emulsion (cream) (test sample (external composition for skin)) having the composition shown in Table 2.
一方、比較例1は表1に記載する割合で、水を攪拌しながらカルボキシビニルポリマーを加えて更に攪拌し、そこにグリセリンを加えてクリーム状の被験試料(皮膚外用組成物)を調整した。比較例1の調製工程はすべて室温でおこなった。 On the other hand, in Comparative Example 1, a carboxyvinyl polymer was added while stirring water at a ratio described in Table 1, and the mixture was further stirred, and glycerin was added thereto to prepare a creamy test sample (external composition for skin). All the preparation steps of Comparative Example 1 were performed at room temperature.
(2)実験方法
下記の手順に従って、被験試料(実施例1〜4、比較例1)の塗布前後で、皮膚被験部位の経上皮水分蒸散量(TEWL)を測定し、上記被験試料の皮膚バリア機能増強作用を評価した。
(i)ヒト(n=17)の上腕内側部(被験部位)のTEWLを、携帯型閉鎖チャンバー方式水分蒸散量測定装置(VAPO SCAN AS-VT100RS:株式会社アサヒテクノラボ製)で測定する。
(ii)SDSの4%水溶液を不織布(15mm×15mm)に含浸させて、これを上記被験部位に30分間貼付し、その後に剥がす。これを4日間繰り返し、被験部位の肌を荒らす。
(iii)4日後、被験部位のTEWLを再度測定する。
(iv)1週間、被験試料(実施例1〜4、比較例1)の適量(約0.1g/回)を1日2回(朝の起床後と夜の入浴後)、被験部位に塗布する。
(v)塗布開始から1週間後、被験部位のTEWLを再度測定する。
(2) Experimental method According to the following procedure, the transepithelial water transpiration (TEWL) of the skin test site was measured before and after application of the test sample (Examples 1 to 4, Comparative Example 1), and the skin barrier of the test sample was measured. The function enhancing action was evaluated.
(I) The TEWL of the inner side of the upper arm (test site) of a human (n = 17) is measured with a portable closed chamber type moisture transpiration measuring device (VAPO SCAN AS-VT100RS: manufactured by Asahi Technolab Co., Ltd.).
(Ii) A non-woven fabric (15 mm × 15 mm) is impregnated with a 4% aqueous solution of SDS, which is applied to the test site for 30 minutes and then peeled off. This is repeated for 4 days to roughen the skin at the test site.
(Iii) After 4 days, the TEWL of the test site is measured again.
(Iv) Apply an appropriate amount (about 0.1 g / time) of the test sample (Examples 1 to 4, Comparative Example 1) twice a day (after getting up in the morning and bathing at night) for 1 week. .
(V) One week after the start of application, TEWL of the test site is measured again.
なお、比較対照のため、上記(ii)の処置後、被験部位に被験試料を塗布せずそのまま1週間放置しておいた非処理部の実験終了後のTEWLも測定した(未処理群)。 For comparison, TEWL was also measured after the end of the experiment in the non-treated area where the test sample was not applied to the test site and left to stand for 1 week after the treatment of (ii) above (untreated group).
(3)判定方法
各被験試料による処理群の修了後のTEWL値と未処置群の修了後のTEWL値を統計処理して、有意水準5%で有意差の有無を判断する(Wilcoxonの符号付順位和検定(対応のあるt検定)。
(3) Judgment method The TEWL value after completion of the treatment group for each test sample and the TEWL value after completion of the untreated group are statistically processed to determine whether there is a significant difference at a significance level of 5% (signed by Wilcoxon) Rank sum test (corresponding t-test).
(4)実験結果
結果を表2に合わせて示す。
(4) Experimental results The results are shown in Table 2.
有意差ありを○、有意差なしを×とした。 A case where there was a significant difference was indicated as ◯, and a case where there was no significant difference was indicated as ×.
表2に示すように、本発明の組成からなる皮膚外用組成物(実施例1〜4)は、皮膚のバリア機能を改善し増強する作用が強いことが判明した。 As shown in Table 2, it was found that the external composition for skin (Examples 1 to 4) comprising the composition of the present invention has a strong effect of improving and enhancing the barrier function of the skin.
処方例
表4に記載する組成からなる皮膚外用組成物(クリーム剤)を調製した。具体的には、まず表3に記載するA相の成分を表3記載の割合でとり80℃に加熱する。次いでB相の成分を表3記載の割合でとり80℃に加熱する。次いでA相成分の混合物にB相成分の混合物を加えて攪拌する。次いでこれを30℃まで冷却(自然放冷)しながら攪拌して表4に記載の組成からなる乳化物(クリーム剤)を調製した。
Formulation Example An external composition for skin (cream) having the composition described in Table 4 was prepared. Specifically, first, the components of the phase A described in Table 3 are taken at the ratio shown in Table 3 and heated to 80 ° C. Next, the components of phase B are taken at the ratios shown in Table 3 and heated to 80 ° C. Next, the B phase component mixture is added to the A phase component mixture and stirred. Next, the mixture was stirred while cooling to 30 ° C. (natural cooling) to prepare an emulsion (cream) having the composition shown in Table 4.
Claims (6)
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016194611A JP2018052904A (en) | 2016-09-30 | 2016-09-30 | External composition |
JP2024022333A JP2024040521A (en) | 2016-09-30 | 2024-02-16 | External composition |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2016194611A JP2018052904A (en) | 2016-09-30 | 2016-09-30 | External composition |
Related Child Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024022333A Division JP2024040521A (en) | 2016-09-30 | 2024-02-16 | External composition |
Publications (1)
Publication Number | Publication Date |
---|---|
JP2018052904A true JP2018052904A (en) | 2018-04-05 |
Family
ID=61835256
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2016194611A Withdrawn JP2018052904A (en) | 2016-09-30 | 2016-09-30 | External composition |
JP2024022333A Pending JP2024040521A (en) | 2016-09-30 | 2024-02-16 | External composition |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2024022333A Pending JP2024040521A (en) | 2016-09-30 | 2024-02-16 | External composition |
Country Status (1)
Country | Link |
---|---|
JP (2) | JP2018052904A (en) |
Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000212027A (en) * | 1999-01-26 | 2000-08-02 | Kose Corp | Preparation for external use for skin |
JP2002068931A (en) * | 2000-08-23 | 2002-03-08 | Kanebo Ltd | Composition for external use |
JP2003081881A (en) * | 2001-09-05 | 2003-03-19 | Lion Corp | Ointment type dermal external agent composition |
JP2004075661A (en) * | 2002-06-18 | 2004-03-11 | Shiseido Co Ltd | Skin external agent characterized with epidermis basement membrane care, epidermis basement membrane structure formation-accelerating agent |
JP2005213187A (en) * | 2004-01-29 | 2005-08-11 | Kose Corp | Involucrin production promoter |
WO2006134890A1 (en) * | 2005-06-14 | 2006-12-21 | Asahi Kasei Chemicals Corporation | Composition for protection of body surface |
JP2007119431A (en) * | 2005-10-31 | 2007-05-17 | Ichimaru Pharcos Co Ltd | Activator of peroxisome proliferator-activated receptor (ppar) |
JP2007119429A (en) * | 2005-10-31 | 2007-05-17 | Ichimaru Pharcos Co Ltd | Activator of peroxisome proliferator-activated receptor |
JP2007332081A (en) * | 2006-06-15 | 2007-12-27 | Bio21 Kk | Health-and-cosmetic-functional composition, and food/drink and cosmetic each containing the same |
JP2013184936A (en) * | 2012-03-08 | 2013-09-19 | Naris Cosmetics Co Ltd | Cosmetic |
JP2015157772A (en) * | 2014-02-21 | 2015-09-03 | 株式会社ナリス化粧品 | Cell differentiation promoter and cosmetic |
JP2015157771A (en) * | 2014-02-21 | 2015-09-03 | 株式会社ナリス化粧品 | cosmetic |
JP2015157773A (en) * | 2014-02-21 | 2015-09-03 | 株式会社ナリス化粧品 | cosmetic |
JP2015157770A (en) * | 2014-02-21 | 2015-09-03 | 株式会社ナリス化粧品 | cosmetic |
JP2015178473A (en) * | 2014-03-19 | 2015-10-08 | ポーラ化成工業株式会社 | makeup cosmetics |
-
2016
- 2016-09-30 JP JP2016194611A patent/JP2018052904A/en not_active Withdrawn
-
2024
- 2024-02-16 JP JP2024022333A patent/JP2024040521A/en active Pending
Patent Citations (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2000212027A (en) * | 1999-01-26 | 2000-08-02 | Kose Corp | Preparation for external use for skin |
JP2002068931A (en) * | 2000-08-23 | 2002-03-08 | Kanebo Ltd | Composition for external use |
JP2003081881A (en) * | 2001-09-05 | 2003-03-19 | Lion Corp | Ointment type dermal external agent composition |
JP2004075661A (en) * | 2002-06-18 | 2004-03-11 | Shiseido Co Ltd | Skin external agent characterized with epidermis basement membrane care, epidermis basement membrane structure formation-accelerating agent |
JP2005213187A (en) * | 2004-01-29 | 2005-08-11 | Kose Corp | Involucrin production promoter |
WO2006134890A1 (en) * | 2005-06-14 | 2006-12-21 | Asahi Kasei Chemicals Corporation | Composition for protection of body surface |
JP2007119431A (en) * | 2005-10-31 | 2007-05-17 | Ichimaru Pharcos Co Ltd | Activator of peroxisome proliferator-activated receptor (ppar) |
JP2007119429A (en) * | 2005-10-31 | 2007-05-17 | Ichimaru Pharcos Co Ltd | Activator of peroxisome proliferator-activated receptor |
JP2007332081A (en) * | 2006-06-15 | 2007-12-27 | Bio21 Kk | Health-and-cosmetic-functional composition, and food/drink and cosmetic each containing the same |
JP2013184936A (en) * | 2012-03-08 | 2013-09-19 | Naris Cosmetics Co Ltd | Cosmetic |
JP2015157772A (en) * | 2014-02-21 | 2015-09-03 | 株式会社ナリス化粧品 | Cell differentiation promoter and cosmetic |
JP2015157771A (en) * | 2014-02-21 | 2015-09-03 | 株式会社ナリス化粧品 | cosmetic |
JP2015157773A (en) * | 2014-02-21 | 2015-09-03 | 株式会社ナリス化粧品 | cosmetic |
JP2015157770A (en) * | 2014-02-21 | 2015-09-03 | 株式会社ナリス化粧品 | cosmetic |
JP2015178473A (en) * | 2014-03-19 | 2015-10-08 | ポーラ化成工業株式会社 | makeup cosmetics |
Non-Patent Citations (1)
Title |
---|
DERMATOLOGIC CLINICS, 2000, 18(4), PP.597-607, JPN6021007000, 2000, ISSN: 0004844710 * |
Also Published As
Publication number | Publication date |
---|---|
JP2024040521A (en) | 2024-03-25 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101217382B1 (en) | EXTERNAL DERMATOLOGICAL FORMULATION COMPRISING SACCHARIDE DERIVATIVE OF α,α-TREHALOSE | |
KR20190037229A (en) | A synergistic antifungal composition and method thereof | |
KR20030074699A (en) | Cosmetics | |
AU2010248292B2 (en) | Composition for preventing hair loss or for stimulating hair growth | |
JP4414495B2 (en) | Antibacterial agent, skin external preparation and skin cleansing agent containing the same | |
JPH09221410A (en) | Aging preventing skin ointment | |
JP4674286B2 (en) | Emulsifiers and cosmetics | |
JP2003113040A (en) | Antibacterial cosmetic composition | |
JP2009161564A (en) | Therapeutic composition for atopic dermatitis | |
JP6376835B2 (en) | Topical skin preparation | |
JP2017193506A (en) | Skin Cosmetic | |
JPWO2006121210A1 (en) | Skin condition improver | |
JP2005132850A (en) | Compounding agent for cosmetic and cosmetic compounded with the same | |
JP7337476B2 (en) | skin barrier function enhancer | |
JP2004097999A (en) | Emulsifier and cosmetic | |
JP2018052904A (en) | External composition | |
JP6826883B2 (en) | Growth inhibitor for Malassezia fungi, preventive or therapeutic agent for Malassezia fungal skin disease, and method for eradicating, removing or suppressing growth of Malassezia fungus | |
JP7433743B2 (en) | Emulsified composition with pearl-like luster | |
JP6862176B2 (en) | Emulsified composition | |
BR112020019017A2 (en) | AGENTS TO IMPROVE SKIN CONDITION | |
KR100774550B1 (en) | Topical formulation for the treatment of dermatological conditions | |
JP2005145938A (en) | Active oxygen scavenger and cosmetic | |
JP2003238429A (en) | Fibroblast cell-activating agent and skin external agent containing the same | |
CN114099410B (en) | Face cream composition of liposome with synergistic gain and anti-aging effects and preparation method thereof | |
JP4246150B2 (en) | Skin cosmetic composition |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A621 | Written request for application examination |
Free format text: JAPANESE INTERMEDIATE CODE: A621 Effective date: 20190808 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20200624 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20200707 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20200907 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20210309 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20210506 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20211019 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20211208 |
|
A131 | Notification of reasons for refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A131 Effective date: 20220426 |
|
A601 | Written request for extension of time |
Free format text: JAPANESE INTERMEDIATE CODE: A601 Effective date: 20220624 |
|
A521 | Request for written amendment filed |
Free format text: JAPANESE INTERMEDIATE CODE: A523 Effective date: 20220721 |
|
A02 | Decision of refusal |
Free format text: JAPANESE INTERMEDIATE CODE: A02 Effective date: 20220809 |
|
C60 | Trial request (containing other claim documents, opposition documents) |
Free format text: JAPANESE INTERMEDIATE CODE: C60 Effective date: 20221104 |
|
A761 | Written withdrawal of application |
Free format text: JAPANESE INTERMEDIATE CODE: A761 Effective date: 20240219 |